|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
DE3380726D1
(en)
|
1982-06-24 |
1989-11-23 |
Japan Chem Res |
Long-acting composition
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
JPH01207920A
(ja)
|
1988-02-16 |
1989-08-21 |
Oki Electric Ind Co Ltd |
ＩｎＰ半導体薄膜の製造方法
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5270202A
(en)
|
1989-11-03 |
1993-12-14 |
Syamal Raychaudhuri |
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
IE911869A1
(en)
|
1990-06-01 |
1991-12-04 |
Regeneron Pharma |
A family of map2 protein kinases
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
AU679167B2
(en)
|
1991-09-20 |
1997-06-26 |
Amgen, Inc. |
Glial derived neurotrophic factor
|
|
US5412087A
(en)
|
1992-04-24 |
1995-05-02 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
DK0618968T3
(da)
|
1991-12-06 |
2000-04-10 |
Max Planck Gesellschaft |
Midler til diagnostisering og behandling af Alzheimer's sygdom
|
|
US5624807A
(en)
|
1992-07-22 |
1997-04-29 |
The Mclean Hospital Corporation |
Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms
|
|
ES2156149T3
(es)
|
1992-12-04 |
2001-06-16 |
Medical Res Council |
Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
|
|
AU6445894A
(en)
|
1993-03-19 |
1994-10-11 |
Duke University |
Method of treatment of tumors with an antibody binding to tenascin
|
|
GB9316727D0
(en)
|
1993-08-12 |
1993-09-29 |
Inst Of Psychiatry |
Models of alzheimers's disease
|
|
AU683703B2
(en)
|
1993-10-20 |
1997-11-20 |
Duke University |
Method of binding material to the beta-amyloid peptide
|
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
DE69534530T2
(de)
|
1994-08-12 |
2006-07-06 |
Immunomedics, Inc. |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
WO1996006862A1
(en)
|
1994-08-26 |
1996-03-07 |
Human Genome Sciences, Inc. |
Gabaa receptor epsilon subunit
|
|
DE69535901D1
(de)
|
1994-10-28 |
2009-01-29 |
Max Planck Gesellschaft |
Proteinkinase npk-110
|
|
US6835555B1
(en)
|
1994-11-01 |
2004-12-28 |
Human Genome Sciences, Inc. |
Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5650313A
(en)
|
1995-06-05 |
1997-07-22 |
Human Genome Sciences, Inc. |
Ubiquitin conjugating enzymes 8 and 9
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
GB9506197D0
(en)
|
1995-03-27 |
1995-05-17 |
Hoffmann La Roche |
Inhibition of tau-tau association.
|
|
US6576607B1
(en)
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
US6221645B1
(en)
|
1995-06-07 |
2001-04-24 |
Elan Pharmaceuticals, Inc. |
β-secretase antibody
|
|
JP4073955B2
(ja)
|
1995-07-07 |
2008-04-09 |
ダーウィン モレキュラー コーポレイション |
アルツハイマー病に関連する第１染色体の遺伝子および遺伝子産物
|
|
US6156311A
(en)
|
1995-07-27 |
2000-12-05 |
The American National Red Cross |
Modulators of expression and function of LRP in alzheimer's disease
|
|
US5695937A
(en)
|
1995-09-12 |
1997-12-09 |
The Johns Hopkins University School Of Medicine |
Method for serial analysis of gene expression
|
|
FR2741892B1
(fr)
|
1995-12-04 |
1998-02-13 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
|
|
US5936078A
(en)
|
1995-12-12 |
1999-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
DNA and protein for the diagnosis and treatment of Alzheimer's disease
|
|
AUPN896596A0
(en)
|
1996-03-27 |
1996-04-26 |
Walter And Eliza Hall Institute Of Medical Research, The |
Therapeutic molecules
|
|
WO1997037228A1
(en)
|
1996-03-29 |
1997-10-09 |
The Trustees Of Boston University |
Methods for diagnosing and treating alzheimer's disease
|
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
|
US5663059A
(en)
|
1996-05-10 |
1997-09-02 |
Incyte Pharmaceuticals, Inc. |
Human phospholipase inhibitor
|
|
US6010878A
(en)
|
1996-05-20 |
2000-01-04 |
Smithkline Beecham Corporation |
Interleukin-1 β converting enzyme like apoptotic protease-6
|
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
|
PT966533E
(pt)
|
1997-02-07 |
2010-01-26 |
Univ Ramot |
Factor neurotrófico iii dependente da actividade (adnf iii)
|
|
US6413940B1
(en)
|
1997-02-07 |
2002-07-02 |
Nymox Corporation |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS
|
|
US6087153A
(en)
|
1997-07-24 |
2000-07-11 |
The Trustees Of Columbia University In The City Of New York |
Sel-10 and uses thereof
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
US7384910B2
(en)
|
1997-10-08 |
2008-06-10 |
Castillo Gerardo M |
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7189703B2
(en)
|
1998-01-09 |
2007-03-13 |
Intracell, Llc |
Treatment and diagnosis of alzheimer's disease
|
|
GB9816575D0
(en)
|
1998-07-31 |
1998-09-30 |
Zeneca Ltd |
Novel compounds
|
|
AU5065399A
(en)
|
1998-08-06 |
2000-02-28 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
US20050032675A1
(en)
|
1998-08-06 |
2005-02-10 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
DE69925133T2
(de)
|
1998-08-27 |
2006-01-19 |
Spirogen Ltd., Ryde |
Pyrrolobenzodiazepine
|
|
WO2000017345A1
(en)
|
1998-09-17 |
2000-03-30 |
Otsuka Pharmaceutical Co., Ltd. |
Ly6h gene
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
WO2000032805A1
(en)
|
1998-12-02 |
2000-06-08 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
|
|
US6982089B2
(en)
|
1999-02-24 |
2006-01-03 |
Tact Ip, Llc |
Cytokine antagonists for neurological and neuropsychiatric disorders
|
|
DE19909357A1
(de)
|
1999-03-03 |
2000-09-07 |
Gerd Multhaup |
Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt
|
|
DE19910108C2
(de)
|
1999-03-08 |
2001-02-22 |
Falk Fahrenholz |
Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie
|
|
AU4055000A
(en)
|
1999-04-13 |
2000-11-14 |
Daniel K. Hsu |
Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
|
|
US6303576B1
(en)
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
EP1201754A4
(en)
|
1999-07-08 |
2005-02-09 |
Fujisawa Pharmaceutical Co |
FACTOR ASSOCIATED WITH APOPTOSIS
|
|
EP1074634B1
(en)
|
1999-07-09 |
2002-10-02 |
Institut Pasteur De Lille |
Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease
|
|
AU783964B2
(en)
|
1999-08-06 |
2006-01-05 |
S.I.S.S.A. Scuola Internazionale Superiore Di Studi Avanzati |
Non-human transgenic animals for the study of neurodegenerative syndromes
|
|
AU784568B2
(en)
|
1999-09-03 |
2006-05-04 |
Ramot At Tel-Aviv University Ltd |
Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
|
|
US6255054B1
(en)
|
1999-09-09 |
2001-07-03 |
Jacques Hugon |
Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease
|
|
JP4969006B2
(ja)
|
1999-09-17 |
2012-07-04 |
学校法人慶應義塾 |
神経細胞死を抑制するポリペプチド、Ｈｕｍａｎｉｎ
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
ATE490979T1
(de)
|
2000-02-14 |
2010-12-15 |
Takeshi Iwatsubo |
Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
|
|
DE1257584T1
(de)
|
2000-02-24 |
2003-05-28 |
Lilly Co Eli |
Humanisierte antikörper, die amyloid beta peptid demarkieren
|
|
US20060148712A1
(en)
|
2000-03-13 |
2006-07-06 |
Fu-Tong Liu |
Monocyte chemoattractant activity of galectin-3
|
|
US7186681B2
(en)
|
2000-03-13 |
2007-03-06 |
La Jolla Institute For Allergy And Immunology |
Methods of modulating cell migration using galectin-3
|
|
CN1450908A
(zh)
|
2000-06-28 |
2003-10-22 |
普拉纳生物技术有限公司 |
神经毒性寡聚体
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
CA2414772C
(en)
|
2000-07-07 |
2011-06-28 |
Jan Naslund |
Prevention and treatment of alzheimer's disease
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
WO2002026246A2
(en)
|
2000-09-29 |
2002-04-04 |
Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh |
Pharmaceutical compositions comprising polynucleotides encoding a raf protein
|
|
US7471798B2
(en)
|
2000-09-29 |
2008-12-30 |
Knowles Electronics, Llc |
Microphone array having a second order directional pattern
|
|
KR100395254B1
(ko)
|
2000-10-30 |
2003-08-21 |
(주)자리타 바이오텍 |
종양 발생 예측 키트
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
CA2671776C
(en)
*
|
2001-01-31 |
2012-12-18 |
H. Lundbeck A/S |
Gal3 receptor antagonists for the treatment of depression
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
AU2002254029A1
(en)
|
2001-02-27 |
2002-09-12 |
Daniel L. Alkon |
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
ATE401576T1
(de)
|
2001-04-14 |
2008-08-15 |
Evotec Neurosciences Gmbh |
Verwendung eines zum kern beschränkten protein für die diagnose und therapie von alzheimer- krankheit und relatierte neurodegeneratiefe störungen
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
EP2165714B1
(en)
|
2001-04-30 |
2013-10-23 |
Eli Lilly And Company |
Humanized antibodies recognizing the beta-amyloid peptide
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
DE10130247A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-3 sowie dessen Verwendungen
|
|
DE10130166A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-1 sowie dessen Verwendungen
|
|
US6831699B2
(en)
|
2001-07-11 |
2004-12-14 |
Chang Industry, Inc. |
Deployable monitoring device having self-righting housing and associated method
|
|
DE60226036T9
(de)
|
2001-08-03 |
2016-09-29 |
Medical & Biological Laboratories Co., Ltd. |
ANTIKÖRPER, DER DAS GM1-GANGLIOSID-GEBUNDENE AMYLOID-b-PROTEIN ERKENNT, UND DNA, DIE FÜR DIESEN ANTIKÖRPER CODIERT
|
|
EP1423704B1
(en)
|
2001-09-07 |
2010-04-14 |
Takeda Pharmaceutical Company Limited |
Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
DE60303360T2
(de)
|
2002-02-14 |
2006-09-21 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung des caps
|
|
WO2003074558A2
(en)
|
2002-03-04 |
2003-09-12 |
Nymox Corporation |
Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
|
|
WO2003076455A2
(en)
|
2002-03-05 |
2003-09-18 |
Ramot At Tel-Aviv University Ltd. |
Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
ATE365175T1
(de)
|
2002-03-21 |
2007-07-15 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung von humanen maguinproteinen und nukleinsäuren bei neurodegenerativen krankheiten
|
|
ATE514707T1
(de)
|
2002-04-19 |
2011-07-15 |
Univ Toronto |
Immunologisches verfahren und zusammensetzungen für die behandlung der krankheit von alzheimer
|
|
EP1497661B1
(en)
|
2002-04-24 |
2009-11-25 |
EVOTEC Neurosciences GmbH |
Diagnostic use of ensadin-0477 gene and protein for neurodegenerative diseases
|
|
US20050032673A1
(en)
|
2002-06-10 |
2005-02-10 |
John Constance M. |
Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease
|
|
US7409040B2
(en)
|
2002-06-21 |
2008-08-05 |
Reuven Avrohom Cyrulnik |
System and method for noninvasive diagnostic imaging, detection, and identification of substances by microwave/RF modulation of x-rays and applications in treatment of diseases characterized by the presence of pathological macromolecules or by the need for regeneration of normal tissue
|
|
AU2003260301A1
(en)
|
2002-06-27 |
2004-01-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
|
|
US7141137B2
(en)
|
2002-07-10 |
2006-11-28 |
University Of Maine System Board Of Trustees |
Method of making laminated wood beams with varying lamination thickness throughout the thickness of the beam
|
|
US20060167227A1
(en)
|
2002-07-12 |
2006-07-27 |
Axon Neuroscience Forschungs-Und Entwicklungs Gmbh |
Truncated tau proteins
|
|
EP2338510A1
(en)
|
2002-07-19 |
2011-06-29 |
Novartis Pharma AG |
Vaccine compositions containing amyloid beta1-6 antigen arrays
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US20040146512A1
(en)
|
2002-10-09 |
2004-07-29 |
Arnon Rosenthal |
Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
NZ567324A
(en)
|
2003-02-01 |
2009-08-28 |
Wyeth Corp |
Active immunization to generate antibodies to soluble A-beta
|
|
EP1590673B1
(en)
|
2003-02-04 |
2009-04-15 |
EVOTEC Neurosciences GmbH |
Diagnostic use of scn2b for alzheimer's disease
|
|
ATE468886T1
(de)
|
2003-02-10 |
2010-06-15 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
US20040223971A1
(en)
|
2003-04-07 |
2004-11-11 |
Glycogenesys, Inc. |
Composition and uses of galectin antagonists
|
|
DE602004014485D1
(de)
|
2003-04-07 |
2008-07-31 |
Prospect Therapeutics Inc |
Zusammensetzung und anwendungen von galectin-antagonisten
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
ES2246178B1
(es)
|
2003-05-08 |
2007-03-01 |
Universidad De Zaragoza. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2004111654A2
(en)
|
2003-06-06 |
2004-12-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in ischaemic heart disease
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
US7384523B2
(en)
|
2003-07-10 |
2008-06-10 |
Radiometer Medical Aps |
Chloride ion selective membrane and sensor
|
|
ES2284018T3
(es)
|
2003-07-28 |
2007-11-01 |
Sig Technology Ltd. |
Tapon vertedor con dispositivo cortador punzante para embases combinados o recipientes cerrados con meterial en laminas.
|
|
WO2005016876A2
(en)
|
2003-08-08 |
2005-02-24 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a benzamide substituent
|
|
AR045219A1
(es)
|
2003-08-08 |
2005-10-19 |
Pharmacopeia Inc |
Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
|
|
US7625711B2
(en)
|
2003-09-05 |
2009-12-01 |
Hisamitsu Pharmaceutical Co., Inc. |
Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
|
|
AT413336B
(de)
|
2003-09-12 |
2006-02-15 |
Mattner Frank Dr |
Apherese-vorrichtung
|
|
EP1670943B1
(en)
|
2003-09-30 |
2013-11-13 |
Evotec International GmbH |
Diagnostic and therapeutic use of a sulfotransferase for alzheimer's disease
|
|
US7700823B2
(en)
|
2003-10-02 |
2010-04-20 |
Aventis Pharma S.A. |
Transgenic animals exhibiting major disorders related to Alzheimer's disease
|
|
CA2541006C
(en)
|
2003-10-03 |
2015-02-17 |
Brigham And Women's Hospital |
Tim-3 polypeptides
|
|
GB0416511D0
(en)
|
2003-10-22 |
2004-08-25 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
EP1678505B1
(en)
|
2003-10-29 |
2014-08-06 |
Evotec International GmbH |
Diagnostic and therapeutic use of the human dax- 1 gene and protein for neurodegenerative diseases
|
|
US9296820B2
(en)
|
2003-11-05 |
2016-03-29 |
Roche Glycart Ag |
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
US20050158321A1
(en)
|
2003-12-17 |
2005-07-21 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with galectin-3 antagonists
|
|
WO2005063761A1
(en)
|
2003-12-19 |
2005-07-14 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
|
US7807157B2
(en)
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
|
US8060179B1
(en)
|
2006-11-16 |
2011-11-15 |
Scientific Nanomedicine, Inc. |
Biomagnetic detection and treatment of Alzheimer's Disease
|
|
EP1721008B1
(en)
|
2004-03-03 |
2010-02-24 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
|
|
JP2007528400A
(ja)
|
2004-03-09 |
2007-10-11 |
エラン ファーマシューティカルズ，インコーポレイテッド |
置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
|
|
WO2005085260A1
(en)
|
2004-03-09 |
2005-09-15 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
|
JP4792390B2
(ja)
|
2004-03-29 |
2011-10-12 |
株式会社ガルファーマ |
新規ガレクチン９改変体タンパク質及びその用途
|
|
CA2564432A1
(en)
|
2004-04-27 |
2005-11-10 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Human anti-amyloid .beta. peptide antibody and fragment of said antibody
|
|
US7629443B2
(en)
|
2004-06-02 |
2009-12-08 |
New York Blood Center, Inc. |
Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
|
|
EP1794313B1
(en)
|
2004-06-21 |
2013-05-15 |
Proteome Sciences Plc |
Screening methods using c-abl, fyn and syk in combination with tau protein
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
AT500483B1
(de)
|
2004-07-13 |
2006-01-15 |
Mattner Frank Dr |
Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
|
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
WO2006014638A2
(en)
|
2004-07-19 |
2006-02-09 |
The General Hospital Corporation |
ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS
|
|
US20060024667A1
(en)
|
2004-07-29 |
2006-02-02 |
Karen Manucharyan |
Compositions and methods for Alzheimer's disease
|
|
CA2575340A1
(en)
|
2004-07-28 |
2006-02-09 |
Schering Corporation |
Macrocyclic beta-secretase inhibitors
|
|
GEP20105110B
(en)
|
2004-08-03 |
2010-11-10 |
Transtech Pharma Inc |
Rage fusion proteins and their use
|
|
CA2576405A1
(en)
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
Antibody and utilization of the same
|
|
JP2008508893A
(ja)
|
2004-08-11 |
2008-03-27 |
エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー |
形質膜ａｔｐアーゼの診断及び治療への使用
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
ATE459650T1
(de)
|
2004-10-08 |
2010-03-15 |
Univ Liege |
KOMPLEMENTÄRE PEPTIDE FÜR ß-AMYLOID 29-42-PEPTID
|
|
US9907485B2
(en)
|
2004-10-15 |
2018-03-06 |
Brainlab Ag |
Targeted immunization and plaque destruction against Alzheimer's disease
|
|
US7811563B2
(en)
|
2004-10-25 |
2010-10-12 |
Northwestern University |
Anti-addl antibodies and uses thereof
|
|
US8288352B2
(en)
|
2004-11-12 |
2012-10-16 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the N terminus
|
|
US7625560B2
(en)
|
2004-12-15 |
2009-12-01 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2006067198A2
(en)
|
2004-12-22 |
2006-06-29 |
Direvo Biotech Ag |
Targeted use of engineered enzymes
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US7632634B2
(en)
|
2005-04-15 |
2009-12-15 |
University Of Maryland Biotechnology Institute |
Method and assay for early diagnosis of prostate cancer
|
|
WO2006112553A2
(en)
|
2005-04-20 |
2006-10-26 |
Dnavec Corporation |
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
US7612062B2
(en)
|
2005-04-21 |
2009-11-03 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
EP1879613B1
(en)
|
2005-05-05 |
2011-11-30 |
Merck Sharp & Dohme Corp. |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
US8114620B2
(en)
|
2005-05-30 |
2012-02-14 |
Takeda Pharmaceutical Company Limited |
Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases
|
|
EP1891234B1
(en)
|
2005-06-01 |
2014-12-10 |
Evotec International GmbH |
Use of slc39a12 proteins as target in diagnosis and drug screening in alzheimer's disease
|
|
WO2006138265A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors, preparation and use thereof
|
|
ATE489370T1
(de)
|
2005-06-14 |
2010-12-15 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
|
WO2006134128A2
(en)
|
2005-06-16 |
2006-12-21 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic target adarb2 proteins for neurodegenerative diseases
|
|
ATE439443T1
(de)
|
2005-06-17 |
2009-08-15 |
Ca Nat Research Council |
NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON
|
|
DE102005029729A1
(de)
|
2005-06-24 |
2006-12-28 |
Röchling Automotive AG & Co. KG |
Verkleidungs- oder Gehäuseteil eines Fahrzeugs und Verfahren zu seiner Herstellung
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
US20070021282A1
(en)
|
2005-07-19 |
2007-01-25 |
Karp Shaun A |
Abdominal exercising and strength testing systems
|
|
EP1937720B1
(en)
|
2005-08-18 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
US8507439B2
(en)
|
2005-08-29 |
2013-08-13 |
Angela Shashoua |
Neuroprotective and neurorestorative method and compositions
|
|
US9133267B2
(en)
|
2005-11-22 |
2015-09-15 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of Alzheimer's and related diseases
|
|
HRP20140240T4
(hr)
|
2005-11-30 |
2017-02-24 |
Abbvie Inc. |
Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
|
|
JP2009518010A
(ja)
|
2005-11-30 |
2009-05-07 |
アボット・ラボラトリーズ |
ヒトβアミロイドタンパク質の組み換え形態の調製方法及びこれらのタンパク質の使用
|
|
US7977314B2
(en)
|
2005-12-02 |
2011-07-12 |
Amorfix Life Sciences Limited |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
RS52060B
(sr)
|
2006-01-25 |
2012-04-30 |
Sanofi |
Citotoksični agensi koji sadrže nove derivate tomaimicina
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
JP5097695B2
(ja)
|
2006-02-22 |
2012-12-12 |
株式会社林原 |
抗アミロイドβペプチド抗体産生誘導用のペプチドワクチン
|
|
RU2429244C2
(ru)
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
|
EP2005187A4
(en)
|
2006-03-23 |
2010-04-21 |
Life Technologies Corp |
METHOD AND REAGENTS FOR IN VIVO IMAGING CANCER CELL LINES
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
EP2011513B1
(en)
|
2006-04-25 |
2016-10-19 |
The University of Tokyo |
Therapeutic agents for alzheimer's disease and cancer
|
|
WO2008042024A2
(en)
|
2006-06-01 |
2008-04-10 |
Elan Pharmaceuticals, Inc. |
Neuroactive fragments of app
|
|
US8141022B2
(en)
|
2006-07-06 |
2012-03-20 |
Nec Corporation |
Method and apparatus for hierarchical design of semiconductor integrated circuit
|
|
CN101501696A
(zh)
*
|
2006-08-14 |
2009-08-05 |
麻省理工学院 |
聚糖数据挖掘系统
|
|
US8759297B2
(en)
|
2006-08-18 |
2014-06-24 |
Armagen Technologies, Inc. |
Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
|
|
WO2008029886A1
(en)
|
2006-09-06 |
2008-03-13 |
National University Corporation Tottori University |
Kit for diagnosis of alzheimer's disease, diagnostic marker, and method for detection of indicator for disease condition
|
|
WO2008036717A2
(en)
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008085564A2
(en)
|
2006-09-20 |
2008-07-17 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods involving truncated recombinant seven g-protein coupled receptors
|
|
EP2094832B1
(en)
|
2006-11-15 |
2015-04-22 |
The J. David Gladstone Institutes |
Methods and compositions for reducing amyloid beta levels
|
|
EP2081961A2
(en)
|
2006-11-15 |
2009-07-29 |
The Brigham and Women's Hospital, Inc. |
Therapeutic uses of tim-3 modulators
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
US8420591B2
(en)
|
2006-12-08 |
2013-04-16 |
Dana-Farber Cancer Institute, Inc. |
MUC1 and galectin-3
|
|
RS60019B1
(sr)
|
2006-12-21 |
2020-04-30 |
H Lundbeck As |
Modulacija aktivnosti proneurotrofina
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
BRPI0806340B8
(pt)
|
2007-01-09 |
2021-05-25 |
Biogen Idec Inc |
anticorpo isolado que se liga especificamente a sp35, seu uso e composição farmacêutica
|
|
TW200844110A
(en)
|
2007-01-11 |
2008-11-16 |
Univ Marburg Philipps |
Diagnosis and treatment of alzheimer's disease and other neurodementing diseases
|
|
DK2121754T3
(en)
|
2007-01-18 |
2015-02-23 |
Lilly Co Eli |
Pegylated amyloid BETA FAB
|
|
WO2008112559A1
(en)
|
2007-03-09 |
2008-09-18 |
Regents Of The University Of California |
Suppression of galectin-3 for treating an inflammatory condition
|
|
ES2655868T3
(es)
|
2007-04-20 |
2018-02-22 |
The Chemo-Sero-Therapeutic Research Institute |
Método para aumentar la respuesta inmunitaria con un péptido
|
|
EP2152744A4
(en)
|
2007-04-26 |
2012-02-15 |
Univ Yale |
PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS
|
|
US20100136597A1
(en)
|
2007-04-26 |
2010-06-03 |
Nathalie Demotte |
Method for modularting activity of t lymphocytes
|
|
WO2008141321A1
(en)
|
2007-05-14 |
2008-11-20 |
Medtronic, Inc. |
Methods and device to neutralize soluble toxic agents in the brain
|
|
WO2009008980A2
(en)
|
2007-07-05 |
2009-01-15 |
Schering Corporation |
Tetrahydropyranochromene gamma secretase inhibitors
|
|
EP2178882B1
(en)
|
2007-07-17 |
2013-04-17 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
SI2019104T1
(sl)
|
2007-07-19 |
2013-12-31 |
Sanofi |
Citotoksična sredstva, ki obsegajo nove tomaimicinske derivate, in njihova terapevtska uporaba
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
US8993833B2
(en)
|
2007-08-14 |
2015-03-31 |
Duke University |
Model of Alzheimer's Disease
|
|
WO2009027105A2
(en)
|
2007-08-31 |
2009-03-05 |
Neurimmune Therapeutics Ag |
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
|
|
US8518975B2
(en)
|
2007-09-06 |
2013-08-27 |
Merck Sharp + Dohme Corp. |
Gamma secretase modulators
|
|
EP2527369A3
(en)
|
2007-09-13 |
2012-12-19 |
University Of Zurich Prorektorat Forschung |
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
|
|
EP2224000B1
(en)
|
2007-10-29 |
2020-05-13 |
TAO Health Life Pharma Co., Ltd. |
Antibody and use thereof
|
|
MY155144A
(en)
|
2007-10-29 |
2015-09-15 |
Inst Nat Sante Rech Med |
NEW ANTIBODIES SPECIFIC OF THE ß-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
|
|
EP2207885B1
(en)
|
2007-11-01 |
2013-11-20 |
F. Hoffmann-La Roche AG |
Quadruple transgenic non-human animal
|
|
MX2010005028A
(es)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
KR101397554B1
(ko)
|
2007-11-09 |
2014-05-21 |
재단법인서울대학교산학협력재단 |
치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법
|
|
UA104132C2
(en)
|
2007-11-13 |
2014-01-10 |
Тева Биофармасьютикалз Юесей, Инк. |
Humanized antibodies against tl1a
|
|
EP2207568B1
(en)
|
2007-11-16 |
2017-05-31 |
The Rockefeller University |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
US8349579B2
(en)
|
2007-12-13 |
2013-01-08 |
Wayne State University |
Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
|
|
US8883419B2
(en)
|
2008-01-07 |
2014-11-11 |
Council Of Scientific & Industrial Research |
Methods and kits useful for the identification of astrocytoma, it's grades and glioblastoma prognosis
|
|
ITNA20080006A1
(it)
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
CN102936287B
(zh)
|
2008-02-08 |
2015-09-09 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
CA2716521A1
(en)
|
2008-02-29 |
2009-09-11 |
Baxter Healthcare S.A. |
Anti-amyloid .beta. activity of intravenous immunoglobulin (ivig) in vitro
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
|
AU2009236699B2
(en)
|
2008-04-14 |
2013-09-05 |
Alzinova Ab |
Stable amyloid beta monomers and oligomers
|
|
EP2116556B1
(en)
|
2008-05-09 |
2016-03-23 |
AbbVie Deutschland GmbH & Co KG |
Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
|
|
WO2009146301A1
(en)
|
2008-05-27 |
2009-12-03 |
Yale University |
TARGETING TGF-β AS A THERAPY FOR ALZHEIMER'S DISEASE
|
|
US8969023B2
(en)
|
2008-06-10 |
2015-03-03 |
Eleanore Bennett Charitable Trust #2 |
Methods and compositions for treating alzheimer's disease
|
|
EP2303001A4
(en)
|
2008-06-20 |
2016-07-13 |
Janssen Biotech Inc |
METHOD FOR VERIFYING THE EFFECTIVENESS OF TREATMENT OF NEUROLOGICAL ILLNESSES
|
|
WO2009155609A1
(en)
|
2008-06-20 |
2009-12-23 |
Oklahoma Medical Research Foundation |
IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE
|
|
KR102050040B1
(ko)
|
2008-06-25 |
2019-11-28 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
ＴＮＦα를 저해하는 안정한 가용성 항체
|
|
CN102112488A
(zh)
|
2008-07-01 |
2011-06-29 |
由卫生福利和体育大臣代表的荷兰王国 |
抗淀粉样折叠中间体的疫苗
|
|
AU2009268808A1
(en)
|
2008-07-08 |
2010-01-14 |
Merck Sharp & Dohme Corp. |
Vaccine for the treatment of Alzheimer's disease
|
|
JP5465720B2
(ja)
|
2008-07-08 |
2014-04-09 |
インサイト・コーポレイション |
インドールアミン２，３−ジオキシゲナーゼの阻害剤としての１，２，５−オキサジアゾール
|
|
MX2011000655A
(es)
*
|
2008-07-18 |
2011-03-21 |
Oragenics Inc |
Composiciones para la deteccion y tratamiento de cancer colorrectal.
|
|
GB0813432D0
(en)
|
2008-07-22 |
2008-08-27 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
CA2735578C
(en)
|
2008-08-12 |
2018-10-23 |
Zinfandel Pharmaceuticals, Inc. |
Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
|
|
US8283322B2
(en)
|
2008-08-15 |
2012-10-09 |
Orthopeutics, Lp |
Formulations for nonsurgical exogenous crosslink therapy
|
|
WO2010040029A1
(en)
|
2008-10-02 |
2010-04-08 |
Celtaxsys, Inc. |
Methods of modulating the negative chemotaxis of immune cells
|
|
AU2009340423B2
(en)
|
2008-10-29 |
2014-07-24 |
Bg Medicine, Inc. |
Galectin-3 immunoassay
|
|
US7888035B2
(en)
|
2008-10-30 |
2011-02-15 |
Caris Mpi, Inc. |
Methods for assessing RNA patterns
|
|
JP2012508748A
(ja)
|
2008-11-13 |
2012-04-12 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
MX2011005046A
(es)
|
2008-11-13 |
2011-06-01 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
DE102008037564A1
(de)
|
2008-11-19 |
2010-05-20 |
Forschungszentrum Jülich GmbH |
Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
|
|
US8912145B2
(en)
|
2008-11-28 |
2014-12-16 |
Hokko Chemical Industry Co., Ltd. |
Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
|
|
EP2373338B1
(en)
|
2008-12-03 |
2017-02-15 |
The Johns Hopkins University |
Annexina2 as immunological target
|
|
WO2010070043A1
(en)
|
2008-12-19 |
2010-06-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarkers for the diagnosis of renal allograft and kidney status
|
|
EP2379563B1
(en)
|
2008-12-22 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
US20100196882A1
(en)
|
2009-02-04 |
2010-08-05 |
Avraham Raz |
GALECTIN-3 nsSNP MARKER FOR CANCER
|
|
RU2683325C2
(ru)
|
2009-02-05 |
2019-03-28 |
Иммьюноджен, Инк. |
Новые производные бензодиазепина
|
|
FR2942476B1
(fr)
|
2009-02-20 |
2013-03-15 |
Commissariat Energie Atomique |
Composes de type pyridocarbazole et leurs applications
|
|
HUE055739T2
(hu)
|
2009-03-18 |
2021-12-28 |
Ac Immune Sa |
Eljárás terápiás alkalmazásra
|
|
US9173928B2
(en)
|
2009-03-26 |
2015-11-03 |
Yoh Matsumoto |
DNA vaccine for Alzheimer's disease
|
|
JP2010268789A
(ja)
|
2009-04-24 |
2010-12-02 |
Kumamoto Univ |
細胞医薬の製造方法
|
|
FR2945538B1
(fr)
|
2009-05-12 |
2014-12-26 |
Sanofi Aventis |
Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide.
|
|
EP2258398A1
(en)
|
2009-05-26 |
2010-12-08 |
Araclón Biotech, S. L. |
Albumin-amyloid peptide conjugates and uses thereof
|
|
CN106390107B
(zh)
|
2009-06-10 |
2019-12-31 |
纽约大学 |
病理tau蛋白的免疫靶向
|
|
WO2010146058A1
(en)
|
2009-06-15 |
2010-12-23 |
Vib Vzw |
Bace1 inhibitory antibodies
|
|
WO2010147969A2
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
|
LT2448968T
(lt)
|
2009-06-29 |
2021-05-10 |
Bioarctic Ab |
Antikūnai, atpažįstantys n gale sutrumpintas amiloido protofibriles/oligomerus
|
|
EP2273273A1
(en)
|
2009-07-11 |
2011-01-12 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Inhibitors of the nitration of amyloid ß peptides and their uses in the diagnosis and treatment of alzheimer's disease
|
|
US9312330B2
(en)
|
2009-07-15 |
2016-04-12 |
Fuji Electric Co., Ltd. |
Super-junction semiconductor device
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
SG177679A1
(en)
|
2009-08-07 |
2012-02-28 |
Kyowa Hakko Kirin Co Ltd |
Humanized anti-amyloid-b oligomer antibody
|
|
CN102576028A
(zh)
|
2009-08-25 |
2012-07-11 |
保函医药公司 |
半乳凝集素-3和心脏再同步疗法
|
|
AU2010286501B2
(en)
|
2009-08-28 |
2015-06-11 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind Tau oligomers
|
|
WO2011031720A1
(en)
|
2009-09-11 |
2011-03-17 |
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University |
Bispecific nanobodies as a therapeutic for alzheimer's disease
|
|
DE102009043750A1
(de)
|
2009-09-30 |
2011-08-04 |
Carl Zeiss Meditec AG, 07745 |
Verfahren und Vorrichtung zur Detektion von Ablagerungen im Auge
|
|
EP2489675A4
(en)
|
2009-10-16 |
2013-06-05 |
Univ Kyoto |
ANTIBODIES WITH RECOGNITION OF THE INVERTED STRUCTURE IN AN AMYLOID ß
|
|
WO2011102901A1
(en)
|
2010-02-20 |
2011-08-25 |
Ebiotec (Euroespes Biotechnology) |
Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphingosine-1-phosphate
|
|
JP6190113B2
(ja)
|
2010-03-03 |
2017-08-30 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
オリゴマー特異アミロイドベータエピトープおよび抗体
|
|
JP2013529181A
(ja)
|
2010-03-25 |
2013-07-18 |
ザ ジェイ． デヴィッド グラッドストーン インスティテューツ |
神経障害を治療するための組成物および方法
|
|
CN102946799A
(zh)
|
2010-04-13 |
2013-02-27 |
巴克斯特国际公司 |
脑室增大率在阿尔茨海默病的静脉内免疫球蛋白治疗中的应用
|
|
JP5875083B2
(ja)
|
2010-04-15 |
2016-03-02 |
メディミューン リミテッド |
増殖性疾患治療用ピロロベンゾジアゼピン
|
|
CA2795349C
(en)
|
2010-04-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Targeted pyrrolobenzodiazepine conjugates
|
|
WO2011148668A1
(ja)
|
2010-05-25 |
2011-12-01 |
株式会社 島津製作所 |
大腸がんマーカーガレクチン、採血試料中のガレクチン濃度の分析方法及び大腸がんマーカーガレクチン検出キット
|
|
AU2011263642B2
(en)
|
2010-06-11 |
2014-09-04 |
Isarna Therapeutics Gmbh |
Method for selective oligonucleotide modification
|
|
EP2593475B1
(en)
|
2010-07-14 |
2016-03-02 |
Merck Sharp & Dohme Corp. |
Anti-addl monoclonal antibody and uses thereof
|
|
US10420923B1
(en)
|
2010-08-10 |
2019-09-24 |
Amiram Katz |
Method and device for intrathecal administering of immunoglobulin
|
|
PL3042917T3
(pl)
|
2010-08-12 |
2018-07-31 |
Eli Lilly And Company |
Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie
|
|
WO2012036786A1
(en)
|
2010-09-17 |
2012-03-22 |
University Of L'aquila |
Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
|
|
AU2011323316B2
(en)
|
2010-11-03 |
2016-02-25 |
Immunogen, Inc. |
Cytotoxic agents comprising new ansamitocin derivatives
|
|
WO2012066495A2
(en)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
|
CA2818173C
(en)
|
2010-11-30 |
2022-05-03 |
Genentech, Inc. |
Low affinity blood brain barrier receptor antibodies and uses therefor
|
|
EP2660600B1
(en)
|
2010-12-28 |
2018-08-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Diagnostic drug and diagnostic method for alzheimer's disease
|
|
US20120244174A1
(en)
|
2011-01-31 |
2012-09-27 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
US8728742B2
(en)
|
2011-03-17 |
2014-05-20 |
Critical Care Diagnostics, Inc. |
Methods predicting risk of an adverse clinical outcome
|
|
EP2508212A1
(en)
|
2011-04-05 |
2012-10-10 |
Universitätsklinikum Freiburg |
Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
|
|
US9499610B2
(en)
|
2011-04-08 |
2016-11-22 |
H. Lundbeck A/S |
Antibodies specific to pyroglutamated Aβ
|
|
KR101589135B1
(ko)
|
2011-04-20 |
2016-01-29 |
주식회사 셀앤바이오 |
인간화 항-ｅｍａｐｉｉ 항체 및 이의 용도
|
|
US20140086836A1
(en)
|
2011-05-03 |
2014-03-27 |
Mental Health Research Institute |
Method for detection of a neurological disease
|
|
GB201108490D0
(en)
|
2011-05-18 |
2011-07-06 |
Ucl Business Plc |
Methods and uses
|
|
EP2710024A4
(en)
|
2011-05-19 |
2015-04-29 |
Harvard College |
OSW-1 ANALOGA AND CONJUGATES AND ITS USE
|
|
AR086543A1
(es)
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
|
JP6209159B2
(ja)
|
2011-06-21 |
2017-10-04 |
イミュノジェン・インコーポレーテッド |
ペプチドリンカーを有する新規メイタンシノイド誘導体およびその結合体
|
|
WO2013008402A1
(ja)
|
2011-07-08 |
2013-01-17 |
シャープ株式会社 |
薄膜トランジスタ基板及びそれを備えた表示装置
|
|
GB201113482D0
(en)
|
2011-08-04 |
2011-09-21 |
Univ Liverpool |
Assay
|
|
NO2748201T3
(https=)
|
2011-08-23 |
2018-05-12 |
|
|
|
WO2013042053A2
(en)
|
2011-09-19 |
2013-03-28 |
University Of The Witwatersrand, Johannesburg |
Compounds for use in the treatment of alzheimer's disease
|
|
ME03008B
(me)
|
2011-09-19 |
2018-10-20 |
Axon Neuroscience Se |
Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti
|
|
WO2013044099A1
(en)
|
2011-09-23 |
2013-03-28 |
Siemens Healthcare Diagnostics Inc. |
Cell response assay for cancer and methods of producing and using same
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
US8764695B2
(en)
|
2012-09-28 |
2014-07-01 |
Isaac Eliaz |
Reduction of galectin-3 levels by plasmapheresis
|
|
ES2669068T3
(es)
|
2011-12-08 |
2018-05-23 |
Eliaz Therapeutics, Inc |
Reducción de niveles de galectina-3 mediante plasmaféresis
|
|
US9549953B2
(en)
|
2011-12-08 |
2017-01-24 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
CA2859202A1
(en)
|
2011-12-15 |
2013-06-20 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Identification of two novel biomarkers for niemann-pick disease type c
|
|
US20130164217A1
(en)
|
2011-12-21 |
2013-06-27 |
Meso Scale Technologies, Llc |
Method of diagnosing, preventing and/or treating dementia & related disorders
|
|
KR20140068105A
(ko)
|
2011-12-29 |
2014-06-05 |
타오 헬스 라이프 파마 가부시키가이샤 |
아밀로스페로이드가 결합하여 성숙 신경 세포사를 유발하는 표적 분자, 아밀로스페로이드가 유도하는 신경 세포사를 억제하는 방법 및 물질, 및 그들의 이용
|
|
WO2013106572A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
JP6188728B2
(ja)
|
2012-02-07 |
2017-08-30 |
グローバル・バイオ・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
核酸送達の区画化方法ならびにその組成物および使用
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
WO2013127829A1
(en)
|
2012-02-27 |
2013-09-06 |
Universitat De Barcelona |
Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
WO2013144957A1
(en)
|
2012-03-26 |
2013-10-03 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Cellular markers for diagnosis of alzheimer's disease and for alzheimer's disease progression
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
RU2644242C2
(ru)
|
2012-04-05 |
2018-02-08 |
Ац Иммуне С.А. |
Гуманизированное тау-антитело
|
|
WO2013169890A1
(en)
|
2012-05-08 |
2013-11-14 |
Bg Medicine, Inc. |
Systems and methods for assessing disease risk, status, and prognosis
|
|
EP2847217B1
(en)
|
2012-05-10 |
2017-10-11 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST OLIGOMERS of Amyloid beta
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
US9682143B2
(en)
|
2012-08-14 |
2017-06-20 |
Ibc Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
|
FR2994803B1
(fr)
|
2012-08-30 |
2016-02-26 |
Oreal |
Modulation de la forme des fibres keratiniques
|
|
US9655977B2
(en)
|
2012-08-31 |
2017-05-23 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
HK1212240A1
(en)
|
2012-09-07 |
2016-06-10 |
吉宁特有限公司 |
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
|
|
AU2013315019B2
(en)
|
2012-09-17 |
2017-06-01 |
Galectin Therapeutics, Inc. |
Method for enhancing specific immunotherapies in cancer treatment
|
|
DK3456734T3
(da)
|
2012-10-04 |
2022-04-19 |
Res Found Dev |
Serinproteasemolekyler og behandlinger
|
|
SMT202000340T1
(it)
|
2012-10-15 |
2020-07-08 |
Medimmune Ltd |
Anticorpi contro il beta amiloide
|
|
WO2014082083A1
(en)
|
2012-11-26 |
2014-05-30 |
Caris Science, Inc. |
Biomarker compositions and methods
|
|
US9066928B1
(en)
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
|
US9089614B2
(en)
|
2012-12-21 |
2015-07-28 |
Bioalliance C.V. |
Hydrophilic self-immolative linkers and conjugates thereof
|
|
US9433665B2
(en)
|
2013-01-11 |
2016-09-06 |
Cyvax, Inc. |
Vaccines for protection from and treatment of alzheimer's disease
|
|
JP6372040B2
(ja)
|
2013-02-06 |
2018-08-15 |
公立大学法人横浜市立大学 |
抗セマフォリン３ａ抗体、並びにこれを用いたアルツハイマー病及び免疫・炎症性疾患の治療
|
|
EP2961773B1
(en)
|
2013-02-26 |
2019-03-20 |
Roche Glycart AG |
Bispecific t cell activating antigen binding molecules
|
|
SI2961426T1
(sl)
|
2013-02-26 |
2020-01-31 |
Baxalta GmbH |
Zdravljanje motenj centralnega živčnega sistema z intranazalnim dajanjem imunoglobulina G
|
|
EP3666795A1
(en)
|
2013-03-12 |
2020-06-17 |
Molecular Templates, Inc. |
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
|
|
TWI680766B
(zh)
|
2013-03-13 |
2020-01-01 |
英商梅迪繆思有限公司 |
吡咯并苯并二氮呯及其共軛物
|
|
WO2014151747A1
(en)
|
2013-03-15 |
2014-09-25 |
Ramot At Tel Aviv University Ltd. |
Methods and compositions with immune therapy for treatment of dementia
|
|
EP2968548B1
(en)
|
2013-03-15 |
2020-09-09 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
AU2013203043B2
(en)
|
2013-03-15 |
2016-10-06 |
Takeda Pharmaceutical Company Limited |
Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
US9937231B2
(en)
|
2013-03-27 |
2018-04-10 |
The General Hospital Corporation |
Methods and agents for treating Alzheimer's disease
|
|
HUE044737T2
(hu)
|
2013-05-06 |
2019-11-28 |
Baxalta Inc |
Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel
|
|
WO2014194166A1
(en)
|
2013-05-31 |
2014-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of using il-1 antagonists to treat alzheimer's disease
|
|
EP3013355B1
(en)
|
2013-06-25 |
2019-08-07 |
ICM - Institut du Cerveau et da la Moelle Epinière |
Il-2 for use in treating alzheimer disease and related disorders
|
|
US9645155B2
(en)
|
2013-08-28 |
2017-05-09 |
University Of South Florida |
Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβ40 aggregates
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
WO2015038446A1
(en)
|
2013-09-13 |
2015-03-19 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
WO2015051850A1
(en)
|
2013-10-11 |
2015-04-16 |
Universität Für Bodenkultur Wien |
Compositions containing galectin-3 modulators for the treatment of bone disorders
|
|
AU2014337317A1
(en)
|
2013-10-15 |
2016-09-15 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
GB201319761D0
(en)
|
2013-11-08 |
2013-12-25 |
Nordic Bioscience As |
Biomarkers of disease progression
|
|
AU2014368696A1
(en)
|
2013-12-20 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Humanized anti-Tau(pS422) antibodies and methods of use
|
|
WO2015100353A1
(en)
|
2013-12-27 |
2015-07-02 |
Dignity Health |
Diagnosing and treating alzheimer's disease
|
|
US10272083B2
(en)
|
2014-01-21 |
2019-04-30 |
Acerta Pharma B.V. |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
|
|
CN112851769A
(zh)
|
2014-01-27 |
2021-05-28 |
分子模板公司 |
用于哺乳动物中的去免疫化志贺毒素a亚基效应子多肽
|
|
US20160177284A1
(en)
|
2014-01-27 |
2016-06-23 |
Molecular Templates, Inc. |
Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
|
|
US20210138076A2
(en)
|
2014-01-27 |
2021-05-13 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
HUE045065T2
(hu)
*
|
2014-01-31 |
2019-12-30 |
Novartis Ag |
TIM-3 antitest molekulák és felhasználásaik
|
|
WO2015120058A2
(en)
|
2014-02-05 |
2015-08-13 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
|
EP3102230B1
(en)
|
2014-02-08 |
2021-04-28 |
F. Hoffmann-La Roche AG |
Methods of treating alzheimer's disease
|
|
AR099707A1
(es)
*
|
2014-03-10 |
2016-08-10 |
La Jolla Pharma Co |
Composiciones y métodos para tratar trastornos renales
|
|
JP6935195B2
(ja)
|
2014-03-11 |
2021-09-15 |
モレキュラー テンプレーツ, インク.Molecular Templates, Inc. |
結合領域、志賀毒素ａサブユニットのエフェクター領域、及びカルボキシ末端小胞体局在化シグナルモチーフを含むタンパク質
|
|
ES2809729T3
(es)
|
2014-03-11 |
2021-03-05 |
Molecular Templates Inc |
Proteínas que comprenden regiones efectoras de la subunidad A de la toxina Shiga próximas al extremo amino terminal y regiones de unión de tipo inmunoglobulina de reconocimiento celular capaces de unirse específicamente a HER2/neu/ErbB2
|
|
CA2942245C
(en)
|
2014-03-12 |
2021-11-02 |
Yeda Research And Development Co. Ltd. |
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns
|
|
CN103880963A
(zh)
*
|
2014-04-08 |
2014-06-25 |
江苏匡亚生物医药科技有限公司 |
半乳糖凝集素-3C（Galectin-3C) 抗体融合蛋白的制备方法和用途
|
|
CN106459088A
(zh)
|
2014-04-10 |
2017-02-22 |
辉瑞公司 |
2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
|
|
ES2921180T3
(es)
|
2014-04-16 |
2022-08-19 |
Kyowa Kirin Co Ltd |
Método para medir la toxicidad del CSF humano
|
|
US9737505B2
(en)
|
2014-04-29 |
2017-08-22 |
Glaxosmithkline Intellectual Property Development Limited |
Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
|
|
AU2015258814B2
(en)
|
2014-05-16 |
2018-04-05 |
Synaptec Development Llc |
Clearance of amyloid ss
|
|
CN106604934A
(zh)
|
2014-06-11 |
2017-04-26 |
分子模板公司 |
耐受蛋白酶切割的志贺毒素a亚基效应子多肽和包含其的细胞靶向分子
|
|
US20150377905A1
(en)
|
2014-06-25 |
2015-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of kawasaki disease
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
CN107073297B
(zh)
|
2014-07-08 |
2021-09-14 |
纽约大学 |
Tau显像配体和其在Tau蛋白病的诊断和治疗中的用途
|
|
GB2528098B
(en)
|
2014-07-09 |
2018-11-21 |
Jaguar Land Rover Ltd |
Vehicle camera system
|
|
WO2016005466A2
(en)
|
2014-07-10 |
2016-01-14 |
Bioarctic Neuroscience Ab |
IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES
|
|
EP3177643B1
(en)
|
2014-08-04 |
2019-05-08 |
F.Hoffmann-La Roche Ag |
Bispecific t cell activating antigen binding molecules
|
|
PL3179991T3
(pl)
|
2014-08-11 |
2022-02-14 |
Acerta Pharma B.V. |
Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2
|
|
CN106796243B
(zh)
|
2014-08-14 |
2018-10-12 |
国立大学法人广岛大学 |
判定早产和/或低体重儿生育的风险的方法和用于该方法的试剂盒
|
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
|
CN106794247B
(zh)
|
2014-09-15 |
2022-12-02 |
豪夫迈·罗氏有限公司 |
抗体配制剂
|
|
TWI599358B
(zh)
|
2014-09-16 |
2017-09-21 |
美國禮來大藥廠 |
組合療法
|
|
US10328051B2
(en)
|
2014-09-22 |
2019-06-25 |
Zoser B. Salama |
Proline or proline derivatives for the treatment of dementia
|
|
US9921230B2
(en)
|
2014-10-08 |
2018-03-20 |
Rhode Island Hospital |
Methods for diagnosis and treatment of concussion or brain injury
|
|
WO2016059453A1
(en)
|
2014-10-16 |
2016-04-21 |
Fundacion Fraunhofer Chile Research |
Biomarkers and therapeutic targets for alzheimer's disease
|
|
US10837966B2
(en)
|
2014-11-04 |
2020-11-17 |
Dana-Farber Cancer Institute, Inc. |
Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses
|
|
CN107428820B
(zh)
|
2014-11-19 |
2022-03-22 |
阿克松神经系统科学公司 |
在阿尔茨海默氏病中的人源化tau抗体
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016094639A1
(en)
|
2014-12-10 |
2016-06-16 |
Wisconsin Alumni Research Foundation |
Mini-intronic plasmid dna vaccines in combination with lag3 blockade
|
|
US10464999B2
(en)
|
2015-01-28 |
2019-11-05 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
US10654917B2
(en)
|
2015-01-29 |
2020-05-19 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
US11867696B2
(en)
|
2015-02-06 |
2024-01-09 |
Cell Idx, Inc. |
Antigen-coupled immunoreagents
|
|
TWI669314B
(zh)
|
2015-02-26 |
2019-08-21 |
美國禮來大藥廠 |
針對ｔａｕ之抗體及其用途
|
|
GB201504432D0
(en)
|
2015-03-17 |
2015-04-29 |
Electrophoretics Ltd |
Materials and methods for diagnosis and treatment of alzheimers disease
|
|
US12109346B2
(en)
|
2015-03-27 |
2024-10-08 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
JP2018509994A
(ja)
|
2015-03-27 |
2018-04-12 |
エリアス・セラピューティクス・インコーポレイテッドＥｌｉａｚ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
患者選択的アフェレシス
|
|
GB201505239D0
(en)
|
2015-03-27 |
2015-05-13 |
Neuro Bio Ltd |
Antibody
|
|
CN115925932A
(zh)
|
2015-04-15 |
2023-04-07 |
安奈普泰斯生物有限公司 |
针对白细胞介素36受体（il-36r）的抗体
|
|
IL292798A
(en)
|
2015-05-04 |
2022-07-01 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, preparations containing them and their uses
|
|
HK1248577A1
(zh)
|
2015-05-11 |
2018-10-19 |
F. Hoffmann-La Roche Ag |
治疗狼疮性肾炎的组合物和方法
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
CN107810198B
(zh)
|
2015-05-29 |
2021-09-03 |
艾伯维公司 |
抗cd40抗体及其用途
|
|
EP3303373B1
(en)
|
2015-05-30 |
2020-04-08 |
Molecular Templates, Inc. |
De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same
|
|
EP3302561A4
(en)
|
2015-06-08 |
2019-02-06 |
Debiopharm International SA |
COMBINATIONS OF ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODIES
|
|
US10203342B2
(en)
|
2015-06-11 |
2019-02-12 |
Nanosomix, Inc. |
Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
|
|
WO2016207245A1
(en)
|
2015-06-24 |
2016-12-29 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
|
HUE057952T2
(hu)
|
2015-06-24 |
2022-06-28 |
Hoffmann La Roche |
Anti-transzferrin receptor antitestek testreszabott affinitással
|
|
CN114129737A
(zh)
|
2015-06-30 |
2022-03-04 |
纳米提克斯有限责任公司 |
与清除颗粒相关的组合物和方法
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
WO2017027691A1
(en)
|
2015-08-13 |
2017-02-16 |
New York University |
Antibody-based molecules selective for the {p}ser404 epitope of tau and their uses in the diagnosis and treatment of tauopathy
|
|
WO2017027685A2
(en)
|
2015-08-13 |
2017-02-16 |
New York University |
Antibody-based molecules specific for the truncated asp421 epitope of tau and their uses in the diagnosis and treatment of tauopathy
|
|
US11154620B2
(en)
|
2015-08-18 |
2021-10-26 |
Rakuten Medical, Inc. |
Compositions, combinations and related methods for photoimmunotherapy
|
|
US10282349B2
(en)
|
2015-08-26 |
2019-05-07 |
International Business Machines Corporation |
Method for storing data elements in a database
|
|
IL319047A
(en)
|
2015-08-28 |
2025-04-01 |
Amunix Operating Inc |
Chimeric polypeptide composition and methods for its preparation and use
|
|
AU2016321298A1
(en)
|
2015-09-09 |
2018-03-29 |
The Trustees Of Columbia University In The City Of New York |
Reduction of ER-MAM localized APP-C99 and methods of treating Alzheimer's Disease
|
|
US20180360959A1
(en)
|
2015-09-25 |
2018-12-20 |
Universität Duisburg-Essen |
Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease
|
|
EP3356415B1
(en)
*
|
2015-09-29 |
2024-05-01 |
Amgen Inc. |
Asgr inhibitors for reduzing cholesterol levels
|
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
|
TWI873952B
(zh)
|
2015-10-02 |
2025-02-21 |
瑞士商赫孚孟拉羅股份公司 |
雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
|
|
CN108779167A
(zh)
|
2015-10-28 |
2018-11-09 |
宾夕法尼亚州大学信托人 |
鞘内施用腺伴随病毒载体用于基因治疗
|
|
CA3000924A1
(en)
|
2015-11-09 |
2017-05-18 |
Galecto Biotech Ab |
Novel galactoside inhibitors of galectins
|
|
IL313608A
(en)
|
2015-12-09 |
2024-08-01 |
Hoffmann La Roche |
Antibody against CD20 type II to reduce the formation of antibodies against drugs
|
|
EP3397645B1
(en)
|
2015-12-28 |
2026-03-25 |
Innate Pharma |
Variable regions for nkp46 binding proteins
|
|
CN108779182A
(zh)
|
2015-12-28 |
2018-11-09 |
麻省理工学院 |
具有恒定区突变的双特异性抗体及其用途
|
|
CN109069539A
(zh)
|
2016-02-18 |
2018-12-21 |
恩立夫克治疗有限责任公司 |
用于癌症治疗的联合免疫疗法和细胞因子控制疗法
|
|
EP3423491A1
(en)
|
2016-03-01 |
2019-01-09 |
H. Hoffnabb-La Roche Ag |
Obinutuzumab variants having altered cell death induction
|
|
MX394409B
(es)
*
|
2016-03-04 |
2025-03-24 |
Galectin Sciences Llc |
Compuestos de seleno-galactosida para la prevención y el tratamiento de las enfermedades asociadas con galectina y el uso de los mismos.
|
|
US10894823B2
(en)
|
2016-03-24 |
2021-01-19 |
Gensun Biopharma Inc. |
Trispecific inhibitors for cancer treatment
|
|
JP7251981B2
(ja)
|
2016-03-24 |
2023-04-04 |
バイエル ファーマ アクチエンゲゼルシャフト |
酵素開裂基を有する細胞毒性活性剤のプロドラッグ
|
|
WO2017172757A1
(en)
|
2016-03-29 |
2017-10-05 |
Acadia Pharmaceuticals Inc. |
5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaques
|
|
US11768203B2
(en)
|
2016-03-31 |
2023-09-26 |
University Of Southern California |
Highly sensitive and specific luciferase based reporter assay for antigen detection
|
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
EP3448427A1
(en)
|
2016-04-29 |
2019-03-06 |
CureVac AG |
Rna encoding an antibody
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US9933440B2
(en)
|
2016-05-31 |
2018-04-03 |
Edward J. Goetzl |
Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
|
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
AU2017290703B2
(en)
|
2016-06-28 |
2023-03-30 |
Emergent Biodefense Operations Lansing Llc |
Formulations of brincidofovir
|
|
PH12018502613B1
(en)
|
2016-07-12 |
2023-02-01 |
H Lundbeck As |
Antibodies specific for hyperphosphorylated tau and methods of use thereof
|
|
WO2018017604A1
(en)
|
2016-07-18 |
2018-01-25 |
Cell Idx, Inc. |
Reagent compounds, compositions, kits, and methods for amplified assays
|
|
CA3030754C
(en)
|
2016-07-20 |
2022-04-26 |
Anahit Ghochikyan |
Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
US10076552B2
(en)
|
2016-08-09 |
2018-09-18 |
DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. |
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
|
|
WO2018030405A1
(ja)
|
2016-08-09 |
2018-02-15 |
国立大学法人東京医科歯科大学 |
Ｈｍｇｂ１に対する抗体、及びそれを含有するアルツハイマー病を治療又は予防するための組成物
|
|
AU2017321609C1
(en)
|
2016-08-30 |
2023-11-09 |
Dana-Farber Cancer Institute, Inc. |
Drug delivery compositions and uses thereof
|
|
WO2018058098A1
(en)
|
2016-09-26 |
2018-03-29 |
Yale University |
Compounds and methods for treating or preventing alzheimer's disease
|
|
KR102546471B1
(ko)
|
2016-09-27 |
2023-06-21 |
프레제니우스 카비 도이치란트 게엠베하 |
액상의 약학 조성물
|
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
ES2834484T3
(es)
|
2016-11-21 |
2021-06-17 |
Univ Ruhr Bochum |
Método para la preselección de fármacos para enfermedades de plegamiento incorrecto de proteínas
|
|
EP3548055A4
(en)
|
2016-12-02 |
2020-08-19 |
University of Southern California |
SYNTHETIC IMMUNE RECEPTORS AND THEIR PROCESSES FOR USE
|
|
WO2018106895A1
(en)
|
2016-12-07 |
2018-06-14 |
Molecular Templates, Inc. |
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
|
|
US20200347143A1
(en)
*
|
2016-12-19 |
2020-11-05 |
Glenmark Pharmaceuticals S.A. |
Novel tnfr agonists and uses thereof
|
|
KR102692708B1
(ko)
|
2016-12-20 |
2024-08-07 |
에프. 호프만-라 로슈 아게 |
항-cd20/항-cd3 이중특이성 항체 및 4-1bb(cd137) 작용물질의 병용 요법
|
|
CN110312534B
(zh)
|
2016-12-21 |
2023-04-04 |
拜耳制药股份公司 |
具有酶促可裂解基团的抗体-药物-缀合物(adc)
|
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
CA3048224A1
(en)
|
2016-12-23 |
2018-06-28 |
Bluefin Biomedicine, Inc. |
Anti-sez6l2 antibodies and antibody drug conjugates
|
|
WO2018129188A1
(en)
|
2017-01-04 |
2018-07-12 |
Nanotics, Llc |
Methods for assembling scavenging particles
|
|
MX2019008840A
(es)
|
2017-01-25 |
2019-09-09 |
Molecular Templates Inc |
Moleculas con direccion hacia las celulas que comprenden efectores de la sub-unidad a de la toxina shiga desinmunizados y epitopos de las celulas t cd8+.
|
|
WO2018138709A1
(en)
|
2017-01-30 |
2018-08-02 |
National Research Council Of Canada |
Blood-brain barrier transmigrating compounds and uses thereof
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
US10473672B2
(en)
|
2017-02-09 |
2019-11-12 |
Kaohsiung Chang Gung Memorial Hospital |
Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
|
|
JP7165995B2
(ja)
|
2017-02-21 |
2022-11-07 |
アールイーエムディー バイオセラピューティクス，インコーポレイテッド |
細胞傷害性ｔリンパ球抗原－４（ｃｔｌａ－４）に結合する抗体を使用した癌治療
|
|
WO2018156617A2
(en)
|
2017-02-22 |
2018-08-30 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer / biomacromolecule conjugates
|
|
ES3010117T3
(en)
|
2017-03-27 |
2025-04-01 |
Hoffmann La Roche |
Improved antigen binding receptors
|
|
JP7330942B2
(ja)
|
2017-03-31 |
2023-08-22 |
ジェンマブ ホールディング ビー．ブイ． |
二重特異性抗ｃｄ３７抗体、モノクローナル抗ｃｄ３７抗体、およびそれらの使用方法
|
|
US20230399414A1
(en)
|
2017-03-31 |
2023-12-14 |
Genmab Holding B.V, |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
SG11201909160WA
(en)
|
2017-04-11 |
2019-10-30 |
Inhibrx Inc |
Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same
|
|
CN108728465A
(zh)
|
2017-04-14 |
2018-11-02 |
深圳新诺微环生物科技有限公司 |
一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
|
|
JP7382232B2
(ja)
|
2017-05-02 |
2023-11-16 |
メルク・シャープ・アンド・ドーム・エルエルシー |
抗ｌａｇ３抗体の製剤および抗ｌａｇ３抗体と抗ｐｄ－１抗体との共製剤
|
|
CN113831417B
(zh)
|
2017-05-08 |
2024-10-01 |
上海津曼特生物科技有限公司 |
双特异性重组蛋白及其应用
|
|
KR20200015528A
(ko)
|
2017-05-12 |
2020-02-12 |
갈랙틴 사이언시즈, 엘엘씨 |
전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
|
|
WO2018210898A1
(en)
|
2017-05-18 |
2018-11-22 |
F. Hoffmann-La Roche Ag |
Reduction of application-related side reaction of a therapeutic antibody
|
|
CR20190550A
(es)
|
2017-06-05 |
2020-04-05 |
Janssen Biotech Inc |
Anticuerpos que se unen específicamente a pd-1 y métodos de uso
|
|
US11214835B1
(en)
|
2017-06-06 |
2022-01-04 |
University Of South Florida |
Methods and compositions for diagnosis and management of neurodegerative diseases
|
|
WO2018231759A1
(en)
|
2017-06-12 |
2018-12-20 |
Obsidian Therapeutics, Inc. |
Pde5 compositions and methods for immunotherapy
|
|
JP2020530280A
(ja)
|
2017-07-03 |
2020-10-22 |
トルク セラピューティクス， インコーポレイテッド |
免疫刺激性融合分子およびその使用
|
|
US10662246B2
(en)
|
2017-07-10 |
2020-05-26 |
New York University |
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
|
|
CN111133006A
(zh)
|
2017-07-14 |
2020-05-08 |
西托姆克斯治疗公司 |
抗cd166抗体及其用途
|
|
CN107383192B
(zh)
*
|
2017-07-19 |
2018-08-24 |
深圳市倍诺博生物科技有限公司 |
半乳糖凝集素-3检测试剂盒
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
US20190029970A1
(en)
|
2017-07-31 |
2019-01-31 |
The Chinese University Of Hong Kong |
Fatty acid conjugated nanoparticles and uses thereof
|
|
BR112020001698A2
(pt)
|
2017-08-03 |
2020-07-21 |
Galectin Sciences, Llc |
compostos para prevenção e tratamento de distúrbios médicos e usos dos mesmos
|
|
IL272418B2
(en)
|
2017-08-08 |
2024-09-01 |
Hoffmann La Roche |
Abinotuzumab treatment of a new subgroup of DLBCL patients
|
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
|
WO2019067805A1
(en)
|
2017-09-27 |
2019-04-04 |
University Of Southern California |
NEW PLATFORMS FOR CO-STIMULATION, NEW CAR DESIGNS AND OTHER IMPROVEMENTS FOR ADOPTIVE CELL THERAPY
|
|
EP3466975A1
(en)
|
2017-10-05 |
2019-04-10 |
Laboratoire Français du Fractionnement et des Biotechnologies |
A specific binding molecule directed against galectin-3 protein
|
|
US20200330592A1
(en)
|
2017-10-09 |
2020-10-22 |
Keith Black |
Compositions and methods of treating alzheimer's and other amyloid related diseases
|
|
MX2020003888A
(es)
|
2017-10-18 |
2020-11-06 |
Regenxbio Inc |
Anticuerpos terapeuticos postraduccionalmente modificados completamente humanos.
|
|
CN111770761B
(zh)
|
2017-10-25 |
2024-07-09 |
爱兰细胞技术公司 |
H1.0k180me2抗体、其制造方法和用途
|
|
CA3080128A1
(en)
|
2017-10-31 |
2019-05-09 |
Galectin Sciences, Llc |
Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
WO2019094679A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of California |
BRAIN DELIVERY OF THE BACE INHIBITOR SAPPALPHA, ANTIBODIES, OR INHIBITORY RNA's USING SYNTHETIC EXOSOMES (DEFORMABLE NANOVESICLES, DNVs)
|
|
PE20211453A1
(es)
|
2017-11-29 |
2021-08-05 |
Prothena Biosciences Ltd |
Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|
|
EP3729081B1
(en)
|
2017-12-21 |
2025-02-19 |
F. Hoffmann-La Roche AG |
Car-t cell assay for specificity test of novel antigen binding moieties
|
|
CN109985231A
(zh)
|
2018-01-02 |
2019-07-09 |
上海清流生物医药科技有限公司 |
一种蛋白在制备预防和治疗痴呆症的药物中的应用
|
|
EP3737472A1
(en)
|
2018-01-09 |
2020-11-18 |
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie |
Modulators of c1q, in particular of the interaction of apoe with c1q, and uses of the modulators in the therapy of neuronal diseases and inflammation
|
|
KR101868343B1
(ko)
|
2018-01-16 |
2018-06-18 |
재단법인대구경북과학기술원 |
콧물 시료의 베타 아밀로이드 올리고머를 이용한 알츠하이머 질환의 진행 단계 스크리닝용 조성물 및 이를 이용한 알츠하이머 질환의 진행 단계 스크리닝 방법
|
|
AU2019215202B2
(en)
|
2018-02-01 |
2025-11-13 |
Memorial Sloan Kettering Cancer Center |
Antibodies to Galectin-3 and methods of use thereof
|
|
US12398201B2
(en)
|
2018-02-19 |
2025-08-26 |
New York University |
Tau single domain antibodies
|
|
EP3755350A4
(en)
|
2018-02-23 |
2021-11-03 |
TrueBinding, Inc. |
TREATING CANCER BY BLOCKING THE INTERACTION OF VISTA AND HIS ASSOCIATION PARTNER
|
|
WO2019165240A1
(en)
|
2018-02-23 |
2019-08-29 |
Rhnanopharma |
Nanosuspensions of salsalate and methods of using the same
|
|
EP3759145A4
(en)
|
2018-02-26 |
2022-03-09 |
Minerva Biotechnologies Corporation |
DIAGNOSTIC METHODS USING ANTI-MUC1* ANTIBODIES
|
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
|
SG11202008098TA
(en)
|
2018-03-28 |
2020-10-29 |
Axon Neuroscience Se |
Antibody-based methods of detecting and treating alzheimer's disease
|
|
CN116173238A
(zh)
|
2018-03-29 |
2023-05-30 |
微脉管治疗有限公司 |
用于检测和治疗阿尔茨海默病的组合物及方法
|
|
CN112584901A
(zh)
|
2018-04-04 |
2021-03-30 |
真和制药有限公司 |
用于阻断非糖基化的pd-1多肽之间的相互作用的方法和组合物
|
|
KR20260046525A
(ko)
|
2018-04-11 |
2026-04-07 |
인히브릭스 바이오사이언스, 인크. |
제한된 cd3 결합을 갖는 다중특이적 폴리펩티드 컨스트럭트 및 관련된 방법 및 용도
|
|
JP7318948B2
(ja)
|
2018-04-13 |
2023-08-01 |
国立大学法人京都大学 |
微生物由来化合物を用いたアルツハイマー病の予防、治療、または診断薬
|
|
TWI874314B
(zh)
|
2018-04-16 |
2025-03-01 |
瑞士商赫孚孟拉羅股份公司 |
螯合型放射核種之抗體
|
|
US20210230255A1
(en)
|
2018-04-27 |
2021-07-29 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
US11085935B2
(en)
|
2018-05-03 |
2021-08-10 |
Washington University |
Methods of treating based on site-specific tau phosphorylation
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
WO2019231957A1
(en)
|
2018-05-30 |
2019-12-05 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
WO2019241315A1
(en)
|
2018-06-12 |
2019-12-19 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
WO2019243453A1
(en)
|
2018-06-19 |
2019-12-26 |
Universidad Pablo De Olavide |
Compositions for treating and/or preventing protein-aggregation diseases
|
|
US12280063B2
(en)
|
2018-06-20 |
2025-04-22 |
Sanford Burnham Prebys Medical Discovery Institute |
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
|
|
CA3106212A1
(en)
|
2018-07-11 |
2020-01-16 |
Momenta Pharmaceuticals, Inc. |
Compositions and methods related to engineered fc-antigen binding domain constructs
|
|
US20210324056A1
(en)
|
2018-07-24 |
2021-10-21 |
Eisai R&D Management Co., Ltd. |
Methods of treatment and prevention of alzheimer's disease
|
|
CN121248772A
(zh)
|
2018-08-17 |
2026-01-02 |
Ab工作室有限公司 |
催化抗体和其使用方法
|
|
JP7525160B2
(ja)
|
2018-08-31 |
2024-07-30 |
Ｂｌｏｏｍ Ｔｅｃｈｎｏｌｏｇｙ 株式会社 |
終末糖化産物に対する抗体およびその使用
|
|
CA3111569A1
(en)
|
2018-09-11 |
2020-03-19 |
Washington University |
Anti-trem-2 agonist antibodies
|
|
WO2020061232A1
(en)
|
2018-09-18 |
2020-03-26 |
1 Globe Biomedical Co., Ltd. |
Treatment for non-alcoholic fatty liver disease
|
|
EP3854875B1
(en)
|
2018-09-21 |
2026-01-14 |
Institute of Science Tokyo |
Human monoclonal antibody binding specifically to human hmgb1, and pharmaceutical composition for treating or preventing alzheimer's disease containing said human monoclonal antibody
|
|
BR112021006153A2
(pt)
|
2018-10-04 |
2021-06-29 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
anticorpo monoclonal beta amiloide anti-n-truncado humanizado
|
|
CN113508300A
(zh)
|
2018-10-04 |
2021-10-15 |
曼尼托巴大学 |
用于人类阿尔茨海默病的新型生物标记物
|
|
CN120623346A
(zh)
|
2018-10-11 |
2025-09-12 |
因荷布瑞克斯生物科学公司 |
Pd-1单结构域抗体及其治疗组合物
|
|
EP3867267A1
(en)
|
2018-10-18 |
2021-08-25 |
FundaMental Pharma GmbH |
Novel means to modulate nmda receptor-mediated toxicity
|
|
EP3643319A1
(en)
|
2018-10-25 |
2020-04-29 |
Grifols Worldwide Operations Limited |
Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages
|
|
US20220089704A1
(en)
|
2018-10-29 |
2022-03-24 |
Biogen Ma Inc. |
Humanized and stabilized fc5 variants for enhancement of blood brain barrier transport
|
|
BR112021008139A2
(pt)
|
2018-10-29 |
2021-08-03 |
Cyclo Therapeutics, Inc. |
métodos para tratar doença de alzheimer
|
|
US12534526B2
(en)
|
2018-11-07 |
2026-01-27 |
Shanghai Hyamab Biotech Co., Ltd. |
NKG2A antibody, preparation method therefor and application thereof
|
|
CA3120970A1
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
JP2022510218A
(ja)
|
2018-11-30 |
2022-01-26 |
メモリアル スローン ケタリング キャンサー センター |
ヘテロ二量体四価特異性抗体およびこれらの使用
|
|
CN121714327A
(zh)
|
2018-12-04 |
2026-03-24 |
脑部保护私人有限公司 |
包括用于治疗病症的可植入阻尼装置和治疗剂的组合疗法及相关系统和使用方法
|
|
US12365724B2
(en)
|
2018-12-10 |
2025-07-22 |
New York University |
Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 and methods of detecting thereof
|
|
UA128001C2
(uk)
|
2018-12-21 |
2024-03-06 |
Ф. Хоффманн-Ля Рош Аг |
Націлені на пухлину агоністичні cd28-антигензв'язувальні молекули
|
|
CA3122321A1
(en)
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Galectin-3 inhibiting c-glycosides
|
|
JP2022037257A
(ja)
|
2018-12-27 |
2022-03-09 |
クリニジェン株式会社 |
アルツハイマー病を治療又は予防する為の抗ウイルス剤及びその使用
|
|
EP3911371A4
(en)
|
2019-01-18 |
2023-04-26 |
University of Southern California |
METHODS AND COMPOSITIONS FOR IMPROVING THE SAFETY AND EFFICACY OF CELL THERAPY
|
|
WO2020154475A1
(en)
|
2019-01-23 |
2020-07-30 |
Molecular Templates, Inc. |
Proteins comprising modified immunoglobulin variable light chains
|
|
WO2020160156A2
(en)
*
|
2019-01-30 |
2020-08-06 |
Immutics, Inc. |
Anti-gal3 antibodies and uses thereof
|
|
CN111518205B
(zh)
|
2019-02-01 |
2022-03-29 |
长春金赛药业有限责任公司 |
人源化抗Aβ单克隆抗体及其应用
|
|
WO2020163817A1
(en)
|
2019-02-08 |
2020-08-13 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
MY206596A
(en)
|
2019-02-08 |
2024-12-25 |
Janssen Pharmaceuticals Inc |
Method of safe administration of phosphorylated tau peptide vaccine
|
|
EP3696192A1
(en)
|
2019-02-15 |
2020-08-19 |
Consejo Superior De Investigaciones Científicas |
Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease
|
|
PL240124B1
(pl)
|
2019-02-21 |
2022-02-21 |
Univ Jagiellonski |
Sposób określania stopnia uszkodzenia nerek pojawiającego się u chorych z cukrzycą
|
|
CA3131019A1
(en)
|
2019-02-22 |
2020-08-27 |
Memorial Sloan Kettering Cancer Center |
Cd33 antibodies and methods of using the same to treat cancer
|
|
WO2020176672A1
(en)
|
2019-02-26 |
2020-09-03 |
Cytomx Therapeutics, Inc. |
Combined therapies of activatable immune checkpoint inhibitors and conjugated activatable antibodies
|
|
US20220160710A1
(en)
|
2019-03-08 |
2022-05-26 |
University Of Virginia Patent Foundation |
Compositions and methods for treating or preventing alzheimer's disease
|
|
KR20220022112A
(ko)
|
2019-03-21 |
2022-02-24 |
이뮤노젠 아이엔씨 |
세포-결합 제제-약물 콘쥬게이트를 준비하는 방법
|
|
JOP20210265A1
(ar)
|
2019-03-26 |
2023-01-30 |
Janssen Pharmaceutica Nv |
الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
|
|
CN113661172A
(zh)
|
2019-03-29 |
2021-11-16 |
伊缪诺金公司 |
用于抑制异常细胞生长或治疗增生性疾病的细胞毒性双苯并二氮杂䓬衍生物及其与细胞结合剂的缀合物
|
|
SG11202110810WA
(en)
|
2019-03-29 |
2021-10-28 |
Torque Therapeutics Inc |
Immunotherapeutic compositions and use thereof
|
|
CN113795262A
(zh)
|
2019-04-08 |
2021-12-14 |
东莞凡恩世生物医药有限公司 |
人源化抗dll3嵌合抗原受体及其用途
|
|
WO2020219868A1
(en)
|
2019-04-24 |
2020-10-29 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
JOP20210284A1
(ar)
|
2019-04-24 |
2023-01-30 |
Janssen Pharmaceuticals Inc |
الإعطاء غير المتجانس للقاحات تاو
|
|
SG11202110922QA
(en)
|
2019-04-26 |
2021-10-28 |
Immunogen Inc |
Camptothecin derivatives
|
|
DE202020006093U1
(de)
|
2019-05-06 |
2025-04-09 |
The Regents Of The University Of California |
Nicht-HLA-Marker der Transplantatabstoßung
|
|
US20230212250A1
(en)
|
2019-05-09 |
2023-07-06 |
University Of The Witwatersrand, Johannesburg |
A method of decreasing concentration of tau (t) protein and/or phosphorylated tau (t) protein
|
|
AU2020275415B2
(en)
|
2019-05-14 |
2026-01-15 |
Genentech, Inc. |
Methods of using anti-CD79B immunoconjugates to treat follicular lymphoma
|
|
US20220226514A1
(en)
|
2019-05-17 |
2022-07-21 |
Cytomx Therapeutics, Inc. |
Methods and compositions for determining the biodistribution of activatable anti-cd166 antibody conjugates
|
|
CA3141334A1
(en)
|
2019-06-04 |
2020-12-10 |
Verseau Therapeutics, Inc. |
Anti-psgl-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof
|
|
CN116987197A
(zh)
|
2019-06-20 |
2023-11-03 |
成都恩沐生物科技有限公司 |
共价多特异性抗体
|
|
JP2022544640A
(ja)
|
2019-06-21 |
2022-10-20 |
ユニバーシティ オブ カンザス |
脳疾患の治療に有用な組成物および方法
|
|
CA3143519A1
(en)
|
2019-06-26 |
2020-12-30 |
Volker Schellenberger |
Cd3 antigen binding fragments and compositions comprising same
|
|
WO2020264211A1
(en)
|
2019-06-26 |
2020-12-30 |
Memorial Sloan Kettering Cancer Center |
Anti-cd33 antibodies for treating cancer
|
|
KR20220027993A
(ko)
|
2019-06-28 |
2022-03-08 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
알츠하이머 질환을 치료하기 위한 방법 및 조성물
|
|
AR119303A1
(es)
|
2019-07-01 |
2021-12-09 |
Eisai R&D Man Co Ltd |
Anticuerpo anti-epha4 humano
|
|
EP3994159A4
(en)
|
2019-07-05 |
2023-08-09 |
University of Florida Research Foundation, Incorporated |
METHODS OF TREATING NEUROLOGICAL DISEASES ASSOCIATED WITH THE RAN PROTEIN
|
|
JP7194085B2
(ja)
|
2019-07-09 |
2022-12-21 |
日立Astemo株式会社 |
操舵制御装置、操舵制御方法、及び操舵制御システム
|
|
WO2021009646A1
(en)
|
2019-07-15 |
2021-01-21 |
Cochlear Limited |
Transcutaneous power and data communication link
|
|
CN115175932B
(zh)
|
2019-07-16 |
2025-10-31 |
赛诺菲 |
用于治疗阿尔茨海默病的中和抗β淀粉样蛋白抗体
|
|
EP4002490A4
(en)
|
2019-07-17 |
2023-04-05 |
Kabushiki Kaisha Toshiba |
SOLAR BATTERY MODULE AND TANDEM SOLAR BATTERY
|
|
US20220275037A1
(en)
|
2019-07-19 |
2022-09-01 |
Dingding MO |
ß-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF
|
|
CA3147020A1
(en)
|
2019-08-07 |
2021-02-11 |
Joe G.N. Garcia |
Anti-nampt antibodies and uses thereof
|
|
WO2021028590A1
(en)
|
2019-08-14 |
2021-02-18 |
Boehringer Ingelheim Rcv Gmbh & Co Kg |
Caspase-2 variants
|
|
WO2021041678A1
(en)
|
2019-08-30 |
2021-03-04 |
Qilu Puget Sound Biotherapeutics Corporation |
Anti-cd20 antibodies, anti-cd37 antibodies, and mixtures thereof
|
|
US20220332757A1
(en)
|
2019-09-09 |
2022-10-20 |
Wuhan Yzy Biopharma Co., Ltd. |
Split intein and preparation method for recombinant polypeptide using the same
|
|
WO2021050601A1
(en)
|
2019-09-09 |
2021-03-18 |
Scribe Therapeutics Inc. |
Compositions and methods for use in immunotherapy
|
|
JP2022547513A
(ja)
|
2019-09-09 |
2022-11-14 |
アクソン ニューロサイエンス エスエー |
アルツハイマー病及び軽度認知障害のバイオマーカー及び治療
|
|
CN114340675A
(zh)
|
2019-09-12 |
2022-04-12 |
豪夫迈·罗氏有限公司 |
治疗狼疮性肾炎的组合物和方法
|
|
BR112022005044A2
(pt)
|
2019-09-17 |
2022-07-05 |
Ohio State Innovation Foundation |
Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento
|
|
AU2020351205A1
(en)
|
2019-09-19 |
2022-04-14 |
Igm Biosciences, Inc. |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
US20230340157A1
(en)
|
2019-09-27 |
2023-10-26 |
Beijing Starmab Biomed Technology Ltd |
Monospecific and multi-specific antibodies
|
|
AR122307A1
(es)
|
2019-10-04 |
2022-08-31 |
Chugai Pharmaceutical Co Ltd |
Agente de supresión de la proliferación celular de cáncer cd20 positivo tolerante a obinutuzumab, y composición farmacéutica, medicamento, fabricación, procedimiento de supresión de la proliferación celular, procedimiento de tratamiento, anticuerpo anti-cd20 de tipo ii, compuesto, sus combinaciones, y agente potenciador y agente inductor, relacionados con estos
|
|
WO2021071830A1
(en)
|
2019-10-07 |
2021-04-15 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
CN112641953A
(zh)
|
2019-10-10 |
2021-04-13 |
复旦大学 |
一种靶向功能分子修饰的抗体复合物
|
|
KR20220084095A
(ko)
|
2019-10-22 |
2022-06-21 |
바이오젠 엠에이 인코포레이티드 |
알츠하이머병의 치료를 위한 항-베타-아밀로이드 항체
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
CN115427439A
(zh)
|
2019-10-30 |
2022-12-02 |
德克萨斯A&M大学系统 |
用于双靶标嵌合抗原受体t细胞疗法的蛋白酶开关
|
|
GB201915855D0
(en)
|
2019-10-31 |
2019-12-18 |
Univ Oxford Innovation Ltd |
An extracellular vesicle
|
|
EP4065600A1
(en)
|
2019-11-25 |
2022-10-05 |
Cornell University |
Apoe gene therapy
|
|
AU2020390448A1
(en)
|
2019-11-28 |
2022-07-14 |
Mcmaster University |
Recombinant polypeptides for programming extracellular vesicles
|
|
JP7835441B2
(ja)
*
|
2019-12-06 |
2026-03-25 |
トゥルーバインディング，インコーポレイテッド |
Ｇａｌ３とインスリン受容体又はインテグリンとの相互作用を妨害する抗体及びそれらの使用方法
|
|
US20230046007A1
(en)
|
2019-12-17 |
2023-02-16 |
Cirlo Gmbh |
Tubular shaped elongated catheter device assemblies for interacting with components of bodily fluids, method for recovering cells, cell aggregates and exosomes from a tubular shaped elongated catheter device and smart tubular shaped elongated catheter device assemblies for monitoring interaction with components of bodily fluids
|
|
EP4085251B1
(en)
|
2020-01-02 |
2024-07-31 |
F. Hoffmann-La Roche AG |
Method for determining the amount of a therapeutic antibody in the brain
|
|
BR112022013892A2
(pt)
|
2020-01-13 |
2022-10-04 |
Truebinding Inc |
Anticorpos anti-gal3 e métodos de uso
|
|
EP4095159A4
(en)
|
2020-01-21 |
2024-03-20 |
Shanghai Henlius Biotech, Inc. |
MONOCLONAL ANTI-LAG3 ANTIBODY AND METHOD FOR THE PRODUCTION THEREOF AND ITS USE
|
|
JP7789002B2
(ja)
|
2020-01-29 |
2025-12-19 |
インヒブルクス バイオサイエンシズ インコーポレイテッド |
Ｃｄ２８シングルドメイン抗体ならびにその多価および多重特異性の構築物
|
|
CN115066610A
(zh)
|
2020-02-05 |
2022-09-16 |
住友制药株式会社 |
用于tau病变和痴呆相关疾病的确定试剂和确定方法
|
|
JP2023514972A
(ja)
|
2020-02-12 |
2023-04-12 |
ザ スクリプス リサーチ インスティテュート |
長時間作用型ｇｍ－ｃｓｆおよび使用方法
|
|
WO2021163681A2
(en)
|
2020-02-14 |
2021-08-19 |
The Trustees Of Columbia University In The City Of New York |
Combination of retromer pharmacological chaperones and exogenous retromer for the treatment of alzheimer's disease and other neurodegenerative diseases and disorders
|
|
EP4107177A4
(en)
|
2020-02-17 |
2024-06-19 |
Board of Regents, The University of Texas System |
CHIMERIC SCAVENGER RECEPTORS TARGETED TO PHOSPHORYLATED TAU (PTHO) AND USES THEREOF
|
|
US12595311B2
(en)
|
2020-03-02 |
2026-04-07 |
The Regents Of The University Of California |
Chimeric antigen receptors and related methods and compositions for the treatment of cancer
|
|
GB202003428D0
(en)
|
2020-03-10 |
2020-04-22 |
Univ Dundee |
IL-10 mutiens
|
|
CN113384710A
(zh)
|
2020-03-14 |
2021-09-14 |
杭州星鳌生物科技有限公司 |
新型免疫激动剂复合物的组成及其在抗多种疾病药物中的应用
|
|
CA3171906A1
(en)
|
2020-03-16 |
2021-09-23 |
University Of Southern California |
Novel antigen binding domains and synthetic antigen receptors incorporating the same
|
|
CN113402612A
(zh)
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
US20230212255A1
(en)
|
2020-03-17 |
2023-07-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereof
|
|
US20230104705A1
(en)
|
2020-03-17 |
2023-04-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and application thereof
|
|
US20230143984A1
(en)
|
2020-03-20 |
2023-05-11 |
Heidelberg University |
Colloidal carrier systems for transfer of agents to a desired site of action
|
|
WO2021195020A1
(en)
|
2020-03-23 |
2021-09-30 |
G3 Pharmaceuticals, Inc. |
Methods and compositions for preventing and treating fibrosis resulting from a coronavirus infection
|
|
EP4122489A4
(en)
|
2020-03-24 |
2023-04-12 |
Talengen International Limited |
METHODS AND MEDICATIONS FOR PROMOTING THE BREAKDOWN OF MISFOLDED PROTEIN AND AGGREGATE THEREOF
|
|
US20230173039A1
(en)
|
2020-03-24 |
2023-06-08 |
Talengen International Limited |
Method and drug for treating alzheimer disease
|
|
CA3174188A1
(en)
|
2020-03-31 |
2021-10-07 |
Neil R. Cashman |
Antibodies to misfolded amyloid beta
|
|
WO2021207312A1
(en)
|
2020-04-07 |
2021-10-14 |
G3 Pharmaceuticals, Inc. |
Methods and compositions for preventing and treating retinal nerve damage
|
|
WO2021207273A1
(en)
|
2020-04-07 |
2021-10-14 |
The Regents Of The University Of California |
Manufacturing of synthetic exosomes for cns and non-cns delivery of therapeutics
|
|
US20230265204A1
(en)
|
2020-04-24 |
2023-08-24 |
Hoffmann-La Roche Inc. |
Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
|
|
CN115916822A
(zh)
|
2020-04-24 |
2023-04-04 |
基因泰克公司 |
使用抗CD79b免疫缀合物的方法
|
|
BR112022023366A2
(pt)
|
2020-05-19 |
2023-05-02 |
Othair Prothena Ltd |
Vacina com múltiplos epítopos para o tratamento de mal de alzheimer
|
|
EP4157338A4
(en)
|
2020-05-26 |
2024-11-13 |
TrueBinding, Inc. |
METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
|
|
EP4157241A4
(en)
|
2020-05-29 |
2025-01-08 |
The Regents of the University of California |
AGENTS AND METHODS FOR THE TREATMENT OF TAUOPATHIES
|
|
EP4157462A1
(en)
|
2020-06-02 |
2023-04-05 |
Dynamicure Biotechnology LLC |
Anti-cd93 constructs and uses thereof
|
|
CN116529260A
(zh)
|
2020-06-02 |
2023-08-01 |
当康生物技术有限责任公司 |
抗cd93构建体及其用途
|
|
TWI843503B
(zh)
|
2020-06-03 |
2024-05-21 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
WO2021248081A1
(en)
|
2020-06-05 |
2021-12-09 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Acvr1 (alk2) receptor inhibition to treat neurological diseases
|
|
KR102225447B1
(ko)
|
2020-06-16 |
2021-03-08 |
부산대학교 산학협력단 |
구강 세균의 군집을 이용한 알츠하이머 진단용 바이오마커 및 이의 용도
|
|
PE20230470A1
(es)
|
2020-06-19 |
2023-03-14 |
Hoffmann La Roche |
Moleculas de union al dominio fc de activacion inmunitaria
|
|
WO2021260193A1
(en)
|
2020-06-25 |
2021-12-30 |
Medimmune Limited |
Prevention of axonal damage using antibody binding to amyloid beta 1-42
|
|
US20210403644A1
(en)
|
2020-06-29 |
2021-12-30 |
University Of South Carolina |
Method For The Degradation Of Endogenous Protein
|
|
WO2022004760A1
(ja)
|
2020-06-30 |
2022-01-06 |
塩野義製薬株式会社 |
抗ｃｃｒ８抗体と化学療法剤の併用
|
|
TW202216777A
(zh)
|
2020-07-10 |
2022-05-01 |
美商生質分子控股有限責任公司 |
四面體抗體
|
|
WO2022020232A1
(en)
|
2020-07-20 |
2022-01-27 |
Genentech, Inc. |
Methods for middle down antibody characterization
|
|
IL299950A
(en)
|
2020-07-20 |
2023-03-01 |
Neotx Therapeutics Ltd |
Superantigen conjugate for use in methods and compositions for the treatment of cancer
|
|
EP4185705A4
(en)
|
2020-07-21 |
2025-01-22 |
Amunix Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS RELATED TO ACTIVATED THERAPEUTIC AGENTS
|
|
US20230322935A1
(en)
|
2020-07-29 |
2023-10-12 |
Dynamicure Biotechnology Llc |
Anti-cd93 constructs and uses thereof
|
|
EP4188408A1
(en)
|
2020-07-30 |
2023-06-07 |
Unigen, Inc. |
A standardized bioflavonoid composition for regulation of homeostasis of host defense mechanism
|
|
EP4188441A1
(en)
|
2020-07-30 |
2023-06-07 |
AnaptysBio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for ichthyosis
|
|
WO2022029051A1
(en)
|
2020-08-03 |
2022-02-10 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
JP2023536602A
(ja)
|
2020-08-03 |
2023-08-28 |
ジェネンテック， インコーポレイテッド |
リンパ腫のための診断及び治療方法
|
|
MX2023001501A
(es)
|
2020-08-07 |
2023-03-08 |
Prothena Biosciences Ltd |
Vacuna tau para tratamiento de enfermedad de alzheimer.
|
|
WO2022032166A1
(en)
|
2020-08-07 |
2022-02-10 |
Othair Prothena Limited |
Multiepitope vaccine for the treatment of alzheimer's disease
|
|
IL300534A
(en)
|
2020-08-11 |
2023-04-01 |
Kanaph Therapeutics Inc |
A fusion protein containing 12-il and an anti-fap antibody, and its use
|
|
EP4186926A4
(en)
|
2020-08-28 |
2024-06-05 |
Harbour Biomed US, Inc. |
ANTI-CCR8 ANTIBODIES AND CORRESPONDING APPLICATION
|
|
EP4129335A4
(en)
|
2020-09-01 |
2024-04-24 |
RemeGen Co., Ltd. |
ANTI C-MET DRUG-ANTIBODY CONJUGATE AND ITS APPLICATIONS
|
|
US20230364210A1
(en)
|
2020-09-17 |
2023-11-16 |
Othair Prothena Limited |
ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
|
|
JP2023541482A
(ja)
|
2020-09-18 |
2023-10-02 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
バイオマーカー法および使用法
|
|
CN116438191A
(zh)
|
2020-09-18 |
2023-07-14 |
欧萨尔普罗席纳有限公司 |
治疗阿尔茨海默病之多表位疫苗
|
|
KR20230074146A
(ko)
|
2020-09-24 |
2023-05-26 |
에프. 호프만-라 로슈 아게 |
T 세포 이중특이성 항체 관련 역효과의 예방 또는 완화
|
|
WO2022072538A1
(en)
|
2020-09-30 |
2022-04-07 |
Biotheryx, Inc. |
Antibody-drug conjugates, pharmaceutical compositions thereof, and their therapeutic applications
|
|
CA3198102A1
(en)
|
2020-10-07 |
2022-04-14 |
Dren Bio, Inc. |
Anti-dectin-1 antibodies and methods of use thereof
|
|
EP4010378B1
(en)
|
2020-10-16 |
2026-05-06 |
LaNova Medicines Limited |
Anti-ccr8 monoclonal antibodies and uses thereof
|
|
JP2023547447A
(ja)
|
2020-10-28 |
2023-11-10 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
改良型抗原結合受容体
|
|
WO2022101120A1
(en)
|
2020-11-10 |
2022-05-19 |
F. Hoffmann-La Roche Ag |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
WO2022125482A1
(en)
|
2020-12-08 |
2022-06-16 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
CN114656562B
(zh)
|
2020-12-23 |
2023-11-03 |
北京天广实生物技术股份有限公司 |
结合人和猴cd3的抗体及其应用
|
|
JP2024503826A
(ja)
|
2021-01-06 |
2024-01-29 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
Ｐｄ１－ｌａｇ３二重特異性抗体及びｃｄ２０ ｔ細胞二重特異性抗体を用いる併用療法
|
|
WO2022150644A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for acne
|
|
WO2022150642A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa
|
|
EP4284824A4
(en)
|
2021-01-27 |
2025-03-12 |
AbelZeta Inc. |
CHIMERIC ANTIGEN RECEPTORS TARGETING CD20
|
|
EP4286406A4
(en)
|
2021-01-29 |
2025-07-23 |
Illimis Therapeutics Inc |
FUSION MOLECULE WITH NON-INFLAMMATORY PHAGOCYTOSIS-INDUCING ACTIVITY
|
|
KR20230153529A
(ko)
|
2021-02-19 |
2023-11-06 |
프리트 엠. 쇼드하리 |
다양한 면역세포를 위한 단일사슬 및 다중사슬 합성 항원 수용체
|
|
AU2022238526A1
(en)
|
2021-03-15 |
2023-09-07 |
F. Hoffmann-La Roche Ag |
Compositions and methods of treating lupus nephritis
|
|
BR112023018676A2
(pt)
|
2021-03-18 |
2023-10-10 |
Seagen Inc |
Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco
|
|
CA3213625A1
(en)
|
2021-03-18 |
2022-09-22 |
Seagen Inc. |
Selective drug release from internalized conjugates of biologically active compounds
|
|
AU2022241940A1
(en)
|
2021-03-23 |
2023-10-26 |
Pieris Pharmaceuticals Gmbh |
Her2/4-1bb bispecific fusion proteins for the treatment of cancer
|
|
WO2022200478A1
(en)
|
2021-03-24 |
2022-09-29 |
Pieris Pharmaceuticals Gmbh |
Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine kinase inhibitor
|
|
WO2022204282A1
(en)
|
2021-03-24 |
2022-09-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bicistronic chimeric antigen receptors designed to reduce retroviral recombination and uses thereof
|
|
WO2022200525A1
(en)
|
2021-03-26 |
2022-09-29 |
Innate Pharma |
Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
|
|
WO2022212918A1
(en)
|
2021-04-02 |
2022-10-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bispecific molecules and related compositions and methods
|
|
CN117597150A
(zh)
|
2021-04-20 |
2024-02-23 |
思进公司 |
抗体依赖性细胞毒性的调节
|
|
WO2022223651A1
(en)
|
2021-04-23 |
2022-10-27 |
F. Hoffmann-La Roche Ag |
Prevention or mitigation of nk cell engaging agent-related adverse effects
|
|
JP2024515968A
(ja)
|
2021-04-26 |
2024-04-11 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体製剤およびその使用法
|
|
CA3213632A1
(en)
|
2021-04-30 |
2022-11-03 |
F. Hoffmann-La Roche Ag |
Dosing for combination treatment with anti-cd20/anti-cd3 bispecific antibody and anti-cd79b antibody drug conjugate
|
|
TW202244059A
(zh)
|
2021-04-30 |
2022-11-16 |
瑞士商赫孚孟拉羅股份公司 |
用抗ｃｄ２０／抗ｃｄ３雙特異性抗體進行治療之給藥
|
|
WO2022235622A2
(en)
|
2021-05-04 |
2022-11-10 |
Biocove Llc |
Cd20 targeting fusion proteins and methods of use thereof
|
|
EP4337694A1
(en)
|
2021-05-12 |
2024-03-20 |
Dana-Farber Cancer Institute, Inc. |
Lag3 and gal3 inhibitory agents, xbp1, cs1, and cd138 peptides, and methods of use thereof
|
|
JP2024518536A
(ja)
|
2021-05-12 |
2024-05-01 |
アナプティスバイオ インコーポレイティッド |
抗体組成物
|
|
IL308351A
(en)
|
2021-05-12 |
2024-01-01 |
Genentech Inc |
Methods for using anti-CD79B immunoconjugates to treat diffuse large B-cell lymphoma
|
|
AU2022283467A1
(en)
|
2021-05-28 |
2023-12-07 |
Seagen Inc. |
Anthracycline antibody conjugates
|
|
AR126009A1
(es)
|
2021-06-02 |
2023-08-30 |
Hoffmann La Roche |
Moléculas agonistas de unión al antígeno cd28 que se dirigen a epcam
|
|
EP4347042A1
(en)
|
2021-06-04 |
2024-04-10 |
Xencor, Inc. |
Dosing of a bispecific antibody that binds cd20 and cd3
|
|
US20220411514A1
(en)
|
2021-06-08 |
2022-12-29 |
Truebinding, Inc. |
Anti-gal3 antibodies and methods of use for insulin resistance
|
|
WO2022258691A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
|
|
BR112023025331A2
(pt)
|
2021-06-09 |
2024-02-27 |
Innate Pharma |
Proteína multiespecífica, composição farmacêutica, célula recombinante, ácido nucleico ou conjunto de ácidos nucleicos, uso de uma proteína ou composição, métodos ou uso
|
|
WO2022258678A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
|
|
KR20240019786A
(ko)
|
2021-06-09 |
2024-02-14 |
이나뜨 파르마 에스.에이. |
Cd20, nkp46, cd16에 결합하고 il-2에 접합된 다중특이적 항체
|
|
IL308918A
(en)
|
2021-06-09 |
2024-01-01 |
Shanghai Epimab Biotherapeutics Co Ltd |
Antibodies and bispecific binding proteins that bind OX40 and/or PD-L1
|
|
WO2022266539A2
(en)
|
2021-06-18 |
2022-12-22 |
Therini Bio, Inc. |
ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN γC DOMAIN AND METHODS OF USE
|
|
US20240279321A1
(en)
|
2021-06-18 |
2024-08-22 |
Therini Bio, Inc. |
ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USE
|
|
US20240189341A1
(en)
|
2021-06-22 |
2024-06-13 |
Remegen Co., Ltd. |
Pharmaceutical combination and use thereof
|
|
KR20240025013A
(ko)
|
2021-06-25 |
2024-02-26 |
난징 이뮤노파지 바이오테크 코., 엘티디. |
항-ccr8 항체 및 이의 용도
|
|
US20230201364A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Antibody conjugates and manufacture thereof
|
|
US20230201365A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Modified cd20 antibodies and uses thereof
|
|
JP7826449B2
(ja)
|
2021-07-13 |
2026-03-09 |
ジェネンテック， インコーポレイテッド |
サイトカイン放出症候群を予測する多変量モデル
|
|
JP2024526764A
(ja)
|
2021-07-13 |
2024-07-19 |
トゥルーバインディング，インコーポレイテッド |
タンパク質凝集を防止する方法
|
|
JP2024525727A
(ja)
|
2021-07-14 |
2024-07-12 |
２セブンティ バイオ インコーポレイテッド |
抗体由来の結合ドメインに融合した操作されたｔ細胞受容体
|
|
EP4373859A1
(en)
|
2021-07-22 |
2024-05-29 |
F. Hoffmann-La Roche AG |
Heterodimeric fc domain antibodies
|
|
US20240336697A1
(en)
|
2021-08-07 |
2024-10-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
WO2023019216A2
(en)
|
2021-08-13 |
2023-02-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosing and treating ischemic eye disease
|
|
CN118251411A
(zh)
|
2021-09-29 |
2024-06-25 |
摩德斯医疗股份有限公司 |
抗原结合多肽、抗原结合多肽复合物及其使用方法
|
|
TW202330594A
(zh)
|
2021-09-29 |
2023-08-01 |
美商莫德斯醫療公司 |
抗原結合多肽、抗原結合多肽複合物及其使用方法
|
|
WO2023051727A1
(zh)
|
2021-09-30 |
2023-04-06 |
上海君实生物医药科技股份有限公司 |
结合cd3的抗体及其用途
|
|
AR127271A1
(es)
|
2021-10-09 |
2024-01-03 |
Hutchmed Ltd |
Anticuerpos biespecíficos que se unen específicamente a cd47 y cd20, y usos de los mismos
|
|
CN115746134A
(zh)
|
2021-10-15 |
2023-03-07 |
深圳市睿盟创新生物科技有限公司 |
半乳糖凝集素-3的免疫测定
|
|
KR20230060546A
(ko)
|
2021-10-22 |
2023-05-04 |
상트네어바이오사이언스 주식회사 |
두개의 Fc 도메인을 포함하는 항원 결합 단백질 및 이의 용도
|
|
US20250011418A1
(en)
|
2021-10-29 |
2025-01-09 |
Zielbio, Inc. |
Cancer specific plectin-1 specific antibodies and methods of use thereof
|
|
CN118524852A
(zh)
|
2021-11-09 |
2024-08-20 |
真和制药有限公司 |
治疗或抑制心血管疾病的方法
|
|
IL312652A
(en)
|
2021-11-25 |
2024-07-01 |
Hoffmann La Roche |
Enhanced receptors for antigen binding
|
|
CN118524854A
(zh)
|
2021-12-17 |
2024-08-20 |
北京加科思新药研发有限公司 |
包含可用作sting激动剂的新型化合物的化合物-连接基构建体及其用途
|
|
WO2023116880A1
(en)
|
2021-12-23 |
2023-06-29 |
Concept To Medicine Biotech Co., Ltd. |
Anti-ccr8 antibodies and uses thereof
|
|
EP4458861A1
(en)
|
2021-12-29 |
2024-11-06 |
Sichuan Huiyu Pharmaceutical Co., Ltd. |
Antibody targeting cd3, multispecific antibody, and uses thereof
|
|
MX2024008641A
(es)
|
2022-01-12 |
2024-07-24 |
Biomolecular Holdings Llc |
Anticuerpos tetraedricos.
|
|
US20230220115A1
(en)
|
2022-01-12 |
2023-07-13 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
CN116462765A
(zh)
|
2022-01-20 |
2023-07-21 |
上海君实生物医药科技股份有限公司 |
抗cd3和抗cd20双特异性抗体及其用途
|
|
US20250388669A1
(en)
|
2022-01-21 |
2025-12-25 |
Jieyi Wang |
Multi-specific antibodies in uses thereof in avidity receptor crosslinking and immune modulation
|
|
KR20230119859A
(ko)
|
2022-02-08 |
2023-08-16 |
연세대학교 산학협력단 |
신규 이중타겟 융합항체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
|
|
TW202400643A
(zh)
|
2022-02-28 |
2024-01-01 |
日商帝人製藥股份有限公司 |
神經退化性疾病之治療劑
|
|
GB202203070D0
(en)
|
2022-03-04 |
2022-04-20 |
Iksuda Therapeutics Ltd |
Anti-canag antibody conjugate
|
|
WO2023178289A2
(en)
|
2022-03-17 |
2023-09-21 |
Seagen Inc. |
Camptothecin conjugates
|
|
CN116789820A
(zh)
|
2022-03-18 |
2023-09-22 |
北京天诺健成医药科技有限公司 |
一种新型免疫调节剂的开发和应用
|
|
MX2024011468A
(es)
|
2022-03-23 |
2024-09-25 |
Hoffmann La Roche |
Tratamiento conjunto de un anticuerpo biespecifico anti-cd20/anti-cd3 y quimioterapia.
|
|
JP2025512798A
(ja)
|
2022-03-25 |
2025-04-22 |
サイトムエックス セラピューティクス，インク． |
活性化可能な二重アンカー型マスク化分子及びその使用方法
|
|
US20250215091A1
(en)
|
2022-03-25 |
2025-07-03 |
Les Laboratoires Servier |
Anti-GAL3 Antibodies and Compositions
|
|
EP4504794A1
(en)
|
2022-04-04 |
2025-02-12 |
Dren Bio, Inc. |
Anti-dectin-1 antibodies and methods of use thereof
|
|
US20250223364A1
(en)
|
2022-04-04 |
2025-07-10 |
Dren Bio, Inc. |
Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof
|
|
CA3255500A1
(en)
|
2022-04-08 |
2023-10-12 |
Regeneron Pharmaceuticals, Inc. |
MULTI-PART RECEIVERS AND SIGNALING COMPLEXES
|
|
US20250346681A1
(en)
|
2022-04-11 |
2025-11-13 |
Astrazeneca Ab |
T cell binding proteins
|
|
WO2023198727A1
(en)
|
2022-04-13 |
2023-10-19 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compositions of anti-cd20/anti-cd3 bispecific antibodies and methods of use
|
|
WO2023201299A1
(en)
|
2022-04-13 |
2023-10-19 |
Genentech, Inc. |
Pharmaceutical compositions of therapeutic proteins and methods of use
|
|
AU2023253036A1
(en)
|
2022-04-15 |
2024-10-17 |
Mabsoft Therapeutics |
Conjugate comprising toll-like receptor agonist
|
|
CN117003872A
(zh)
|
2022-04-28 |
2023-11-07 |
北京天广实生物技术股份有限公司 |
含有突变轻链可变区骨架的单链抗体片段
|
|
AU2023264582A1
(en)
|
2022-05-03 |
2024-11-21 |
Incyte Corporation |
Methods for treating lymphoma
|
|
EP4518905A1
(en)
|
2022-05-06 |
2025-03-12 |
Seagen Inc. |
Immunomodulatory antibody-drug conjugates
|
|
JP2025517476A
(ja)
|
2022-05-25 |
2025-06-05 |
イナート・ファルマ・ソシエテ・アノニム |
ネクチン－４結合剤
|
|
US20230416412A1
(en)
|
2022-05-31 |
2023-12-28 |
Hoffmann-La Roche Inc. |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
CN117323429A
(zh)
|
2022-07-01 |
2024-01-02 |
广东克冠达医药科技有限公司 |
Cd101的抗体及其用途
|
|
JP2025524628A
(ja)
|
2022-07-12 |
2025-07-30 |
シートムエックス セラピューティクス，インコーポレイテッド |
Ｅｐｃａｍイムノコンジュゲート及びその使用
|
|
EP4562058A1
(en)
|
2022-07-28 |
2025-06-04 |
The Board of Regents of the University of Oklahoma |
Biomarkers, diagnostic methods, treatments, and therapeutics for autoimmune disorders and diseases
|
|
JP2025525904A
(ja)
|
2022-08-03 |
2025-08-07 |
シージェン インコーポレイテッド |
免疫刺激性抗ｐｄ－ｌ１－薬物コンジュゲート
|
|
WO2024036148A1
(en)
|
2022-08-08 |
2024-02-15 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating blood cancers
|
|
EP4321522A1
(en)
|
2022-08-12 |
2024-02-14 |
Seagen Inc. |
Cytotoxic compounds and conjugates thereof
|
|
WO2024040194A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
WO2024220435A1
(en)
|
2023-04-18 |
2024-10-24 |
Truebinding, Inc. |
Methods of treating eye disease
|
|
CN117051537A
(zh)
|
2023-07-03 |
2023-11-14 |
五邑大学 |
一种乙酰化葡甘聚糖静电纺丝膜及其制备方法与应用
|